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ABSTRACT OF DISSERTATION 
 
 
 
 
 
PROMOTION OF EARLY PEDIATRIC HEARING DETECTION THROUGH  
PATIENT NAVIGATION 
 
Congenital hearing loss is the most common neonatal sensory disorder and it is 
crucial to diagnose hearing loss as soon as possible after birth in order to facilitate rapid 
treatment. Universal standards of infant hearing healthcare dictate that infant hearing 
screening should be completed by one month of age and abnormal screening tests 
should be followed with definitive audiological testing by three months of age. Obtaining 
diagnostic testing can be complicated by limited access to care in rural areas, 
breakdowns in communication, lack of parental support, and poor coordination of care. 
There is no established method to address appointment non-adherence in newborn 
hearing testing. Patient navigation (PN), which uses trained healthcare workers to 
educate patients and facilitate adherence to healthcare, is an evidence-based approach 
that has had widespread success in facilitating timely care in other healthcare settings 
but has not been studied in infant hearing testing. The objective of this dissertation is to 
1) assess the effect of patient navigation on care delivery in healthcare inequity settings, 
2) assess the efficacy of a PN intervention to decrease non-adherence to recommended 
infant audiological testing after failed newborn hearing screening, and 3) develop a 
method to implement patient navigation into the state hearing screening program. 
 
The original concept and development of PN stems from the findings of the 
American Cancer Society National Hearings on Cancer in the Poor in 1989, which 
revealed a host of barriers that underserved populations face in receiving timely and 
appropriate, care. Cancer treatment centers have utilized patient navigators (PNs) to 
address these barriers in the delivery of cancer care. In order to consider the potential of 
applying patient navigation in promoting timely infant hearing healthcare, a systematic 
review was performed to systematically assess the efficacy of patient navigation to 
improve diagnosis and treatment of diseases affecting medically underserved 
populations. Specific outcomes assessed in the review included the effect of PN on 
timing of definitive diagnosis and effect on initiation of treatment. The search strategy 
produced 1,428 articles and 16 were included for review. In the Oncology field, timing of 
initial contact with a patient navigator after diagnostic or screening testing was correlated 
to the effectiveness of the navigator intervention. The majority of the studies reported 
significantly shorter time intervals to diagnosis and to treatment with patient navigation. 
This review provided evidence to justify a PN efficacy trial in infant hearing healthcare.
 
To investigate the efficacy of PN to decrease non-adherence to recommended 
infant audiological testing after failed newborn hearing screening, a randomized 
controlled trial was conducted in sixty-one guardian-infant dyads. All infants had 
abnormal newborn hearing screening and were recruited within the first week after birth. 
Dyads were randomized into a PN study arm or standard of care arm. PN was found to 
be efficacious as the percentage of participants with follow-up non-adherence was 
significantly lower in the PN arm compared with the standard of care arm (7.4% versus 
38.2%, p=0.005). The timing of initial follow-up was significantly lower in the PN arm 
compared with the standard of care arm (67.9 days versus 105.9 days, p=0.010). Based 
on this efficacy data, the next objective of the research was to scale up PN to maximize 
public health impact by combining an effectiveness trial with implementation research. A 
hybrid effectiveness/implementation study was designed to investigate patient navigation 
within the state-funded EHDI (early hearing detection and intervention) system. Using a 
stepped wedge design this trial investigates the 1) effectiveness of PN to decrease non-
adherence to hearing testing, 2) implementation factors using the Consolidated 
Framework of Implementation Research (CFIR), and 3) cost-effectiveness and 
sustainability of a PN program within a state-supported EHDI system. 
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CHAPTER ONE: PEDIATRIC HEARING HEALTHCARE DISPARITIES AND 
PATIENT NAVIGATION 
 
1.1 PEDIATRIC HEARING LOSS: A PUBLIC HEALTH CONCERN 
As the most common neonatal sensory disorder in the United States, infant 
hearing loss occurs in 1.6 per 1000 births.1 The sense of hearing is vital and early 
childhood hearing loss can result in lifelong learning delay and disability. The 
consequences of delayed infant hearing loss diagnosis and intervention include 
significant delays in language, cognitive, and social development2 with profound effects 
on education and employment.3 The economic costs of hearing loss are substantial and, 
according to the Centers for Disease Control, the overall lifetime medical, educational, 
and occupational costs due to deafness for children born in 2000 is estimated to be $2.1 
billion.4 
 
1.2 DIAGNOSTIC DELAYS IN PEDIATRIC HEARING LOSS 
The United States Preventive Services Task Force recognizes that early 
diagnosis of hearing loss leads to decreases in language development problems, social 
and emotional challenges, and learning and behavioral disorders.5 Intervention for 
hearing loss prior to 6 months of age has profound effects on language expressive 
measures and social adjustment.6,7 To promote early diagnosis and treatment, all infants 
should be screened no later than 1 month after birth, diagnosis of hearing loss should 
occur before 3 months of age, and hearing loss treatment should occur before 6 months 
of age (1-3-6 rule).8-11 The Joint Committee on Infant Hearing (JCIH) gold standard is that 
no more than 10% of infants would be non-adherent to diagnostic testing by 3 months of 
age;12 however, this standard is not being met. In 2014, 58.9% of U.S. infants failed to 
obtain a diagnosis within 3 months after abnormal screening.1 In spite of efforts to closely 
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document follow-up and promote adherence to timely testing in Kentucky, the state’s non-
adherence rate is still 25.9%, nearly 3 times the JCIH goal.1 In addition, children from 
underserved rural regions such as Appalachia are consistently delayed in diagnosis and 
treatment of hearing loss.13-15  
 
1.3 FACTORS LEADING TO DIAGNOSTIC DELAYS 
Timely adherence to infant diagnostic testing and hearing loss treatment is a 
complex process and parents face many barriers. Early infant hearing detection and 
intervention (EHDI) programs are coordinated by each state and the diagnostic and 
treatment process is complex. Despite multiple streamlining initiatives, many parents find 
the diagnostic process and treatment difficult to navigate.16 Risk of non-adherence is 
higher in families with greater travel distances, low levels of parental education, low 
socioeconomic status, and public insurance.17-20 Families of children with hearing loss 
report that they lack confidence and resources needed for healthcare decision-making for 
their child.21 Many parents lack role models who have been through the complex process 
of hearing loss diagnosis and intervention22 because more than 90% of deaf children 
have hearing parents.23 Consistent with the tenets of Social Cognitive Theory (SCT),24-27 
a complex interaction of personal, interpersonal, and environmental factors influences 
hearing healthcare adherence and access. 
 
1.4 LACK OF EVIDENCE-BASED APPROACHES TO DECREASE INFANT HEARING 
DIAGNOSTIC NON-ADHERENCE 
There are no existing evidence-based approaches to decrease non-adherence to 
infant hearing testing and treatment. Tele-audiology may expand access but requires 
significant resources, and insufficient data are available to support widespread use of this 
strategy.28 Prenatal educational modules29 and social worker counseling30 have not 
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demonstrated significant benefit in promoting rescreening after failed infant hearing 
screening; however, parental contact after postnatal hospital discharge may promote 
rescreening.31 Parent-to-parent programs, such as Guide By Your Side,32 are available in 
many states and may reduce parental isolation and boost parental acceptance of the 
child’s condition.22 However, despite promising data from nearly 2 decades ago, these 
programs are not consistently integrated into state-funded EHDI services and diagnostic 
centers, and when provided they are under-utilized. Additionally, these programs typically 
require the parents to make initial contact to establish services, and they often are not 
utilized until after a diagnosis of hearing loss is made. Evidence regarding the effects and 
optimal implementation of these programs is lacking; in fact, a recent meta-analysis found 
no literature addressing the effectiveness or cost of initiatives designed to 
decrease non-adherence in follow-up after failed newborn hearing screening.33 
 
1.5 THE POTENTIAL OF PATIENT NAVIGATION TO PROMOTE INFANT HEARING 
ADHERENCE 
PN programs can increase healthcare adherence and improve access to care, 
especially in underserved rural populations. PNs are trained healthcare workers who 
assess and mitigate personal, interpersonal, and environmental barriers to healthcare 
adherence and access, consistent with SCT-based approaches to promote healthy 
behaviors.24-27 PNs educate patients on health conditions and healthcare systems while 
facilitating adherence to healthcare recommendations.34 Primarily implemented and 
studied in the cancer field, PN reduces medical non-adherence and hastens diagnosis 
and treatment.35-37 PN programs have been especially effective in assisting patients from 
traditionally underserved backgrounds, including rural Appalachia.38-45 The positive 
patient-level effects of PN (i.e., improved adherence with medical diagnostic testing46-
48 and timely diagnosis and treatment39,46,49) can resulted in significant healthcare cost 
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savings.45 In order to consider the potential for patient navigation in promoting timely 
infant hearing healthcare, it is necessary to obtain a deeper understanding of the role that 
patient navigation has played in healthcare promotion in underserved populations. 
 
 
1.6 PATIENT NAVIGATION IN THE MEDICALLY UNDERSERVED: A SYSTEMATIC 
REVIEW 
1.6.1 Introduction 
 Patient adherence to physician recommended follow-up and treatment plans is 
often a challenge. Martin et al reported in 2005 that up to 40% of patients did not comply 
with their recommended treatment plans. When a patient’s treatment plan is more 
complex or requires active lifestyle changes, that percentage of non-adherence can rise to 
as high as 70%. Such lack of patient compliance can lead to significant complications in 
the patient’s healthcare as well as increased medical expenses.50 Reported factors that 
lead to non-adherence include misunderstanding the recommended follow-up or treatment 
plan, lack of consistency in the patient’s medical care, cultural or health beliefs that conflict 
with the plan, socioeconomic status, mistrust of the healthcare system, and a lack of social 
support for the patient.51  All of these factors serve as potential barriers that doctors, 
nurses, and other providers must assist the patient in overcoming.  
 Patient navigation is an evidence-based intervention created to address non-
adherence and help patients maneuver through personal and systematic barriers in order 
to achieve timely follow-up care for health conditions.52 The role of a patient navigator is to 
assist patients in overcoming challenges that prevent adherence to their healthcare plan, 
allowing them to timely and adequate treatment. The original concept and development of 
this intervention stems from the findings of the American Cancer Society National 
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Hearings on Cancer in the Poor in 1989. These hearings revealed a host of difficulties that 
underserved populations face in receiving timely and appropriate care. Based on these 
findings, Dr. Harold Freeman initiated the first patient navigation program in 1990 to 
promote timely cancer treatment in Harlem, New York.53 Since that pilot program, 
treatment centers worldwide have been using patient navigators to improve the quality and 
timeliness of therapy in a multitude of cancer types. The purpose of this research is to 
systematically evaluate the efficacy of patient navigation in improving timely and 
appropriate diagnosis and treatment of disease in medically underserved populations. We 
hypothesize that patient navigation is effective in improving timely, appropriate follow-up 
care for diagnosis and treatment of chronic illness within underserved populations.  
1.6.2 Methods  
 This study was exempt from Institutional Review Board approval. The Preferred 
Reporting Items for Systematic Reviews and Meta-Analysis54 checklist was used to guide 
this systematic review. A specific outcome measure was not required for inclusion in this 
review. The specific inclusion criteria included: 1) articles pertaining to patient navigation in 
the healthcare setting, 2) articles reporting on the effect of navigation on definitive 
diagnosis, and 3) articles reporting on the effect of navigation on timely initiation of 
treatment, and 4) articles studying patient population designated as underserved. 
Exclusion criteria included: 1) single case reports or non-original research and 2) language 
other than English. 
 Search Strategy: To perform a systematic literature review of patient navigation in 
the underserved, a search string was developed to include patient navigation or similar 
programs used in populations that are medically underserved.  A search string was 
designed to include studies that addressed both (1) patient navigation and (2) medically 
underserved populations. See FIGURE 1.1 for the complete search string. A search 
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strategy was developed using The National Library of Medicine’s (NLM) medical subject 
heading (MeSH) browser in expanded concept view to identify MeSH indexed search 
terms (http://www.nlm.nih.gov/ mesh/MBrowser.html). In an attempt to capture articles 
pertaining to the study objective, MeSH terms associated with “patient navigation” were 
used to ensure that pertinent navigation studies were not excluded based on the title of 
the program. These included barefoot doctors, community health workers, community 
health aides, and health promoter. To identify all relevant articles related to “health 
disparity” the following words were also included: inequality, low-income, poverty, and 
indigent. An initial search was performed in PubMed. [All Fields] was selected to ensure 
that articles that mentioned the pertinent terms in any form would be captured. The search 
was confined to English only papers. The same search string was then used to search 
MEDLINE, PsychINFO, Web of Science, and CINAHL, with duplicates from the four 
searches being removed. Title and abstract reviews were conducted to select articles that 
dealt with human participants and any form of patient navigation and health disparity, 
eliminating case studies, literature reviews, or studies with no reported timing to diagnosis 
or treatment outcomes. The search was performed in August 2015. FIGURE 1.1 lists 
terms utilized in the search string as well as the algorithm for inclusion/exclusion.  
 Data Extraction: Article titles and abstracts were reviewed independently by 2 
reviewers and were selected or removed based on the inclusion and exclusion criteria. In 
the event of disagreement over inclusion, the article was included for full text review to be 
more inclusive. A full-text review of all eligible articles was completed independently by the 
reviewers and the bibliographies of these articles were examined to identify additional 
articles. The two reviewers independently analyzed the articles and results were then 
organized into two tables focusing on the outcomes of (1) effect of navigation on obtaining 
a definitive diagnosis following screening test and (2) effect of navigation on obtaining  
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FIGURE 1.1 – Preferred reporting items for systematic review and meta-analysis 
algorithm 
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treatment following diagnosis. The level of evidence of each article was also assessed 
according to the Oxford Centre for Evidence-based Medicine guidelines.55 
 Bias Assessment: Articles were reviewed independently and scored based on 
accepted bias assessment tools. Randomized controlled studies were analyzed using the 
National Institute of Health Quality Assessment Tool for Controlled Intervention Studies. A 
score was obtained based on the 14-point questionnaire. The authors agreed on a score 
of 10 or above for a low risk of bias, 6-9 for a moderate risk of bias and 5 or less for high 
risk of bias. Retrospective studies were assessed using the Newcastle – Ottawa Scale.56 
The authors agreed on a score of greater than 8 as a low risk for bias, 5-8 for moderate 
risk and less than 5 as high risk of bias. Studies that did not conform to these bias scales 
were not assessed. 
1.6.3 Results  
 Search Results: The initial search of all 4 databases yielded 1,428 articles. After 
the duplicates were removed, 711 articles remained. The titles and abstracts of these 
articles were scanned to determine if they met the study objectives; 683 articles were 
removed through this process. A full text review and scan of the references of the 
remaining twenty-eight articles were performed. Of the twenty-eight, sixteen met the 
inclusion criteria and were eligible for the systematic review. All studies were from the 
field of Oncology. Of these studies, seven used a randomized trial design, five used a 
non-randomized design, two were observational, and two included multiple study sites that 
use different methods. There was a lack in consistency in outcome reporting and 
intervention conditions, thus a meta-analysis was not performed. The type of navigator in 
each study differed; seven of the studies recruited lay people to be trained in the role of a 
navigator, three employed nurses with oncology experience, and six studies used a team 
approach consisting of a lay person and a nurse or an individual with a master’s in social 
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work (MSW). The studies were conducted from 1998-2011, and all were based in the 
United States. The participants in the studies included uninsured, non-English speaking, 
and underserved residents from urban or rural locations. The reported efficacy of 
navigation on diagnosis and treatment are recorded in TABLE 1.1 and TABLE 1.2, 
respectively, along with description of the study sample.  
 Studies with Time to Diagnosis as the Primary Outcome: Fifteen of the articles 
included in the review assessed the effect of patient navigation on timely diagnostic 
resolution following an abnormal cancer screening. The studies varied regarding the 
cancer type included in the trial; six of the articles addressed only patients with abnormal 
breast cancer screenings, one involved cervical cancer, one involved colorectal cancer, 
and the remaining seven included multiple types of cancer including breast, cervical, 
colorectal, and prostate cancers. Diagnostic resolution was defined as a patient obtaining 
follow-up testing that resulted in either a definitive diagnosis of cancer or no cancer.57,58 A 
majority of the studies measured time to diagnosis as the date of the abnormal screening 
to the date diagnostic testing was complete.51,52,57,59-63 Three of the studies placed more 
emphasis on adherence to follow-up appointments; however, these appointments usually 
resulted in diagnostic resolution as well.59,64,65 
 As mentioned previously, the qualifications and characteristics of the navigators 
varied between studies. Some utilized lay navigators who had personal experience with 
the disease and represented the population they were serving (e.g. Hispanic women 
serving as navigators in an area where majority of the patients were also Hispanic). 
Others reported hiring professional health care workers or MSWs to perform navigation 
activities. Some studies included one or more navigators who were bilingual, commonly 
speaking English and Spanish. The structure of navigation also varied across studies. 
While some used a highly structured guide or assessment tool for each patient encounter,
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others used a simple logging system to record barriers or problems addressed during a 
conversation with the patient. Though the execution of navigation differed between the 
articles, the basic services provided and challenges addressed were consistent. The 
articles cited obstacles such as transportation difficulty, lack of insurance, poor 
coordination of healthcare appointments, language barriers, and general 
misunderstanding of the follow-up process as difficulties that navigators helped patients 
overcome. 
 Fourteen of the articles reported significant improvement in obtaining diagnostic 
resolution when a navigator was utilized.51,52,57-67 The remaining article did not find the 
use of a patient navigator to be effective in improving the time from screening to 
diagnosis.68 This outlying study reported a significant gap between the screening test and 
contact with the patient navigator. Over one-third of the patients in that study were not 
contacted by the navigator within the first month following the abnormal screening test.68 
This suggests that timeliness of initial contact by the navigator may influence the efficacy 
of such a program.  Another study reported earlier diagnostic resolution with navigation; 
however, there was no significant difference in cancer stage at time of diagnosis between 
the navigator group and the control group in those patients that were actually diagnosed 
with cancer.67  
 Studies with Time to Treatment as Primary Outcome: Four of the sixteen articles 
included in this review assessed the effect of a patient navigator on time from definitive 
diagnosis to initiation of appropriate treatment. Three of these studies only included 
patients diagnosed with breast cancer; the remaining study included patients who had 
been diagnosed with breast, cervical, colorectal, and prostate cancers. Two of the studies 
utilized a non-randomized design, one used an observational design, and one utilized 
multiple designs to accommodate the needs to each site in their study. These articles 
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also had the same variation in the characteristics and qualifications of their navigators as 
the studies that focused on time to diagnosis, ranging from laypersons to nurses or 
MSWs. Each of the studies defined time to treatment initiation as the time from date of 
definitive diagnosis to the date that treatment was first received.59,60,69,70 Types of 
treatment that were included were radiation, chemotherapy, hormone therapy, and 
surgery.69 All four articles saw a significant decrease in time to treatment initiation or 
improvement of adherence in the navigated patients over the standard of care.  
1.6.3 Discussion  
 Patient compliance to care is a factor that limits the efficacy of all aspects of 
medicine. Within the medically underserved, groups that have limited access to 
healthcare, this is an even larger problem. Patient navigation programs are designed to 
assist patients, specifically ones from underserved populations, in receiving and 
maintaining timely and adequate health care. The studies in this review assessed the 
efficacy of patient navigation in assisting the medically underserved in overcoming 
barriers to their care. All reports came from the field of Oncology. Review of these 
articles yielded themes as to what makes a successful navigation program and which 
patients may benefit most from such programs. First, timeliness of navigation initiation 
plays a role in the success of a program. The non-efficacious program consistently took 
longer to enroll patients into the treatment arm of the study. This suggests that future 
navigation programs would benefit their patients by beginning to navigate those patients 
as soon after an abnormal screening test as possible. These authors suggest that this 
would make the patient-to-navigator relationship more meaningful, and increase the 
likelihood that the patient will receive diagnostic resolution and treatment within the 
necessary timeframe.68  
 The risk of malignant disease on screening testing may have an inverse 
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relationship with patient navigation efficacy. When screening-testing results revealed a 
high risk for cancer patient navigation was less effective as it is likely that key providers of 
care play an active role in expediting diagnostic evaluation. However, patients with low or 
moderate risk of a cancerous lesion on screening testing yielded the highest efficacy 
when navigated versus the control group.62,63 This is proposed to be due to the perceived 
importance of definitive diagnostic evaluation.62,63 A navigator may be able to emphasize 
the importance of definitive diagnostic evaluation in spite of low to moderate risk of 
disease, increasing their rates of adherence to care over control groups. While all 
patients from diverse backgrounds benefit from navigation compared with control groups 
in these studies, programs with limited resources may see the highest efficacy when 
targeting resources towards this specific patient group.  
 This review found that patient navigation is an efficacious intervention to improve 
adherence to receive timely medical care. This is an important issue within Oncology, as 
decreasing time to diagnosis and time to treatment has been shown to decrease 
mortality. Huo et al. found that delays in diagnosis among breast cancer patients 
correlated to increased likelihood of cancer metastasis and lower rates of disease-free 
survival.70 Redaniel et al. describe that the patients receiving colorectal cancer screening 
sooner after diagnosis have higher survival rates.71 Similarly, Dolly et al. found that a 
delay between diagnosis and treatment in endometrial cancer patients was correlated 
with higher disease mortality.72 Although disease survival and treatment outcomes were 
not consistently reported in the studies within this review, patient navigation expedites 
diagnosis and treatment in oncology patients and has the potential to impact survival in 
the treatment of cancer. The cost of navigation was underreported in the studies reviewed 
and this issue remains a concern when considering wide implementation of such 
interventions. In spite of demonstrating more expeditious diagnostic resolution following 
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cancer screening with navigation, Bensink et al reported an increased cost of $275 per 
patient with patient navigation compared with control. The overall value and cost savings 
in patient navigation is likely understated as this study did note patient navigation 
contributed to significantly higher diagnostic resolution and probability of ever having 
diagnostic resolution.66 
 There are limitations of this review as well as the articles included in the review. In 
spite of thorough search criteria, it is possible that relevant articles were excluded from 
this review. Publication bias is also a limitation as equivocal findings in intervention studies 
may not be reported or published. Outcome reporting bias is also a limitation of this 
review but using a protocol such that our hypothesis and methods were determined a 
priori to the knowledge of the results reduced this. Potential biases were reduced in our 
interpretation of the data by employing a systematic approach to our search strategy 
outlined above. Conclusions drawn from this systematic review are limited given that a 
meta-analysis could not be performed.   
 Patient navigation is useful in assisting in care delivery for the underserved. This 
review supports the use of navigation as an effective tool in increasing adherence to care 
in these populations. While certain populations may benefit more from navigation, it has 
been shown to work in diverse groups. In the future, it may be beneficial to investigate 
different delivery methods for patient navigation, the timing of intervention, and factors 
associated with successful patient navigators (i.e. the training and background of patient 
navigators). Further research into the use of navigation in the medically underserved will 
give more insight into potential uses. 
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CHAPTER TWO: PROMOTION OF EARLY PEDIATRIC HEARING DETECTION 
THROUGH PATIENT NAVIGATION: A RANDOMIZED CONTROLLED CLINICAL 
TRIAL 
2.1 ABSTRACT 
2.1.1 Objectives/Hypothesis 
Congenital hearing loss is the most common neonatal sensory disorder and it is 
crucial to diagnose hearing loss as soon as possible after birth in order to facilitate rapid 
treatment. Universal standards of infant hearing healthcare dictate that infant hearing 
screening should be completed by one month of age and abnormal screening tests 
should be followed with definitive audiological testing by three months of age. Obtaining 
diagnostic testing can be complicated by breakdowns in communication, lack of parental 
support, and poor coordination of care. There is no established method to effectively 
educate parents, promote sound decision-making, and assist in coordinating care 
following failed newborn hearing screening testing. Patient navigation, which uses 
trained healthcare workers to educate patients and facilitate adherence to healthcare, is 
an evidence-based approach that has had widespread success in facilitating timely care 
in other healthcare settings but has not been studied in infant hearing testing. The 
objective of this research was to decrease non-adherence (lost to follow-up rates) to 
recommended infant audiological testing after failed newborn hearing screening. We 
aimed to assess the efficacy of a patient navigator intervention to achieve this objective 
and we hypothesized that the utilization of a patient navigator would decrease non-
adherence to obtain audiological testing following failed screening, compared to those 
receiving the standard of care. 
2.1.2 Study Design 
The study design was a randomized controlled clinical study. Guardian-infant 
dyads, in which the infants had abnormal newborn hearing screening, were recruited 
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within the first week after birth. All participants were referred for definitive audiological 
diagnostic testing at either a University-based audiology practice or a state-funded 
audiology clinic. Dyads were randomized into a patient navigator study arm or standard 
of care arm. The primary outcome was the percentage of patients with follow-up non-
adherence to obtain diagnostic testing.  The participant follow up adherence was 
monitored for 6 months after enrollment and the non-adherence rates and timing of 
diagnostic testing were compared between groups.  Secondary outcomes were parental 
knowledge of infant hearing testing recommendations and barriers in obtaining follow-up 
testing, which were obtained at enrollment and at the conclusion of the study through 
entrance and exit questionnaires. 
2.1.3 Results  
Sixty-one dyads were enrolled in the study (patient navigator arm=27, standard 
of care arm=34). PN was found to be efficacious, as the percentage of participants non-
adherent to diagnostic follow-up during the first 6 months after birth was significantly 
lower in the patient navigator arm compared with the standard of care arm (7.4% versus 
38.2%) based on chi-squared test analysis (p=0.005). The timing of initial follow-up was 
significantly lower in the navigator arm compared with the standard of care arm (67.9 
days after birth versus 105.9 days, p=0.010). Patient navigation increased baseline 
knowledge regarding infant hearing loss diagnosis recommendations compared with the 
standard of care (p=0.004). High satisfaction was reported with the patient navigation 
intervention.  
2.1.5 Conclusions  
Patient navigation decreases non-adherence rates following abnormal infant 
hearing screening and improves knowledge of follow-up recommendations. This 
intervention has the potential to improve the timeliness of delivery of infant hearing 
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healthcare and future research is needed to assess the cost and feasibility of larger 
scale implementation. 
 
2.2 MATERIALS AND METHODS 
 
2.2.1 Regulatory and Registration Data 
Institutional review board approval of the protocol was obtained prior to initiating 
the study (protocol 12-1059-P1H). The protocol was registered with ClinicalTrials.gov 
prior to initiating the study (NCT01917747). 
2.2.2 Participants  
We carried out a prospective randomized trial involving a parent or guardian and 
their infant who failed infant hearing screening and were referred for outpatient 
audiological evaluation. Within this population, the majority of primary caregivers are 
mothers and were, thus, the primary candidates for recruitment into this study. The 
parent and their child (the dyad) who were referred for testing were eligible for 
participation in this study if they met enrollment criteria including being a: 1) Parent with 
an infant less than 2 weeks old and born after 34 weeks gestation, 2) Parent whose 
infant failed hearing screening (either automated auditory brainstem response test or 
otoacoustic emission test) in one or both ears in the newborn nursery, 3) Parents with a 
working phone willing to be contacted over the phone by a patient navigator during the 
first year after birth. Exclusion criteria include: 1) Parents whose infant was hospitalized 
more than 2 weeks after birth, 2) Parents whose infant was born prior to 34 weeks 
gestation, 3) Parents of an infant in neonatal intensive care unit, 4) Infants with 
outpatient audiological follow-up less than 2 weeks from the time of enrollment, or 5) 
Infants who are wards of the state and cases of adoption. 
2.2.3 Sample Size Calculation and Recruitment 
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The national non-adherence rate following failed infant hearing screening is 25%1 
and we proposed that the navigator intervention would decrease the non-adherence rate 
to 12%. A power analysis was performed and in order to have 80% power to detect this 
difference (at the 0.05 significance level) a sample size of 60 patients was selected. All 
potential participant dyads were referred for outpatient definitive audiological testing prior 
to discharge from the birthing hospital. Potential participants were identified and 
recruited from 3 primary areas: the newborn nursery of a tertiary University-based 
medical center (children born within the University system and referred to the University 
audiology practice), the same University-based audiology practice (children born outside 
of the University but referred to the University audiology practice), and a state-funded 
audiology clinic (for children born outside and referred outside the University system). 
The recruitment team contacted these areas on a daily basis and verified eligibility. 
Potential participants within the University were contacted in person prior to discharge 
and those outside the University were contacted by phone within 2 weeks after hospital 
discharge. The study was discussed with participants and informed consent was 
obtained.  
2.2.4 Randomization and Study Protocol  
All eligible and enrolled participants were given follow-up appointment dates and 
time prior to enrollment, typically one month after birth but no later than 3 months after 
birth. In describing the study to eligible candidates, the parent or guardian was told that 
their child had referred on a newborn hearing screening for further hearing testing. All 
participants were told that they would be obtaining an outpatient appointment with the 
ability to contact the referral clinic at any time with questions or concerns. Participants 
were told that those agreeing to be involved in the study would be randomized into either 
a group that will proceed with their appointment as scheduled without further contact 
from the research staff or they would be placed in a group that would be contacted by a 
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patient navigator before their appointment. At the time of enrollment and informed 
consent, participants completed a previously tested 26-item entrance questionnaire17 
(APPENDIX 1) assessing knowledge of infant hearing testing recommendations and 
barriers in obtaining follow-up testing. Similar questions regarding knowledge and 
barriers were asked at the end of the study for all participants in a 24-item exit 
questionnaire17 (APPENDIX 2). These questionnaires have been used previously to 
assess parental knowledge, attitudes, and behaviors regarding the EHDI system and 
audiological assessment. Following enrollment, the participant dyad was assigned a 
study number and was randomized (using block randomization with varying block sizes 
to assign participants into either the navigator or standard of care arms). Blocked 
randomization of individuals with variable block sizes (differing numbers of participants 
per block) ensured equal probabilities of group assignment. A biostatistician created the 
computer-generated randomization scheme.  
2.2.5 Patient Navigation Intervention  
Patient navigation was selected as the intervention for this study because it is widely 
effective in other complex healthcare fields, it is extremely useful and appropriate among 
rural and low socioeconomic populations, and there is a lack of evidence to support 
other methods of improving EHDI non-adherence. The Chronic Care Model39 has guided 
the development and implementation of many patient navigator interventions and this 
program incorporates key components of this model (FIGURE 2.1). Based on this 
model, navigators have the potential to assist patient in the identification and recruitment 
of community resources along with health system resources to facilitate delivery of care. 
The patient navigator program (PNP) focused on elimination of breakdowns in 
communication, parent decisional support, and coordination of care through the complex 
EHDI system. An interview guide using semi-structured and open-ended questions was 
developed for this study and was piloted tested with parents of children who have gone  
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Figure 2.1: Chronic Care Model Constructs for Patient Navigation73 
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through the EHDI diagnostic process (APPENDIX 3). Participants randomized to the 
PNP group were assigned to a navigator who contacted the participant by phone within 
5 days following the assignment with expected interview duration between 10-30 
minutes. Through the initial interview, the navigator used the interview guide to assess 
the participants’ fears and concerns regarding infant hearing testing, barriers to 
appointment adherence, and potential connections to community and healthcare system 
support services. Additionally, during the initial interview, the navigator discussed the 1-
3-6 EDHI hearing testing and treatment guidelines. Participants were contacted by 
phone weekly (text and email were also offered as alternative communication methods) 
after the initial interview to address key discussion points: 1) the status of the 
newborn/family and whether newborn hearing testing had occurred, 2) family fears and 
reservations regarding the infant’s hearing, and 3) the parent’s knowledge of the 
recommended testing/treatment and the timing of appointments as well as 
perceived/real barriers to obtaining testing/treatment. During the follow-up interviews, the 
navigator provided education on the standard recommendations of infant hearing 
diagnostic testing/treatment and the importance of timely adherence to recommended 
testing/treatment. The timing of the appointment and the directions to the testing center 
were discussed. The weekly phone sessions occurred during the first six months after 
the birth of the child concluding when the diagnostic testing was performed. Participants 
were given the opportunity to contact the navigator outside of scheduled interviews 
based on their needs, concerns, and questions. 
 Navigators identified specific barriers to care and then assisted participants by 
taking actions tailored to the specific needs of the individual. Social support was 
provided by supportive listening, providing educational materials, and assisting with 
referrals for psychological assistance, if needed. Navigators provided instrumental 
assistance by helping participants with making appointments, resolving child-care  
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problems, and helping with transportation issues. At the participant level, navigators 
educated participants on the 1-3-6 EDHI recommendations for hearing evaluation and 
treatment and counseled them on the importance of adherence to follow-up 
appointments.  
Navigators were selected and trained in accordance with a widely accepted 
model established by the National Cancer Institute Patient Navigator Research Program 
and the American Cancer Society Patient Navigation Program.74 Patient navigators for 
this study included a parent of a child with hearing loss and an adult layperson with 
hearing loss. A bilingual (Spanish-English) navigator was also utilized in this study. The 
navigators were paid hourly by the primary university conducting the study and they 
completed onsite training using multiple modalities that included traditional lectures, 
interactive formats, and role-play with case scenarios. They were trained in the 
complexity of the EHDI hearing healthcare system and in helping patients navigate 
through the process in a timely manner. The navigator’s training involved: 1) rural 
context training, 2) EHDI system and audiological testing training with university 
audiologists and state EHDI coordinators, 3) medical training with an otolaryngologist, 4) 
medical center patient services training with clinical support staff to equip the navigator 
with education regarding logistical problems with obtaining appointments, and 5) 
navigator telephone training. Following the American Cancer Society patient navigator 
model, the navigators contacted participants by telephone.74 Adherence to outpatient 
testing was monitored on a weekly basis. Additional appointment variables were also 
recorded (number of scheduled appointments, number of attended appointments, 
number of rescheduled or “no-show” visits). At the conclusion of the study, participants 
completed the Patient Satisfaction with Navigation questionnaire to assess patient 
satisfaction with the intervention.75 
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2.2.6 Control Group (Standard of Care)  
According to EHDI standards, all parents of children who fail infant hearing 
screening are given printed educational materials and may view an educational video 
regarding infant hearing loss and EHDI services while in the hospital. All participants of 
the standard of care group were given their outpatient follow-up appointment prior to 
discharge. Once the participant was discharged from the hospital and/or enrolled in the 
study he or she did not have any further contact with the research staff. The parent 
participant had access to discuss any questions or concerns with the office or audiology 
staff, as is the standard of care practice, but this was parent-initiated contact. There was 
an automated appointment reminder phone call (which is a medical center standard of 
care) that occurred 48 hours prior to the appointment, which requested confirmation of 
the planned adherence to the clinical appointment. The research staff monitored 
adherence to follow-up of study participants. 
2.2.7 Measures  
The primary outcome was a dichotomous variable based on whether the child 
received the outpatient audiological testing during the first six months after birth. 
Adherence was recorded when the participant presented for the audiological testing in 
the audiology clinic. Adherence and timing of follow-up was confirmed by cross-
referencing with the EHDI state data registry. We also recorded process variables of the 
navigator intervention including number of telephone sessions, number of missed or 
terminated navigator sessions, reasons for missed sessions, length of the sessions, and 
Patient Satisfaction with Navigation questionnaire scores (APPENDIX 4).75 The 
secondary outcome of interest assessed was the time interval from birth to the attended 
initial outpatient ABR appointment during the first 6 months after birth. The time interval 
from birth to final diagnosis was also recorded. Number of no-show office visits and 
rescheduled visits were also recorded. Failure to obtain a follow-up within 6 months after 
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birth was considered as follow-up non-adherence (lost to follow-up) and 180 days was 
designated for these participants in time analyses.  
2.2.8 Analysis  
Data were managed using the REDCap data collection system and was exported 
into an Excel spreadsheet (Microsoft, Redmond, WA, USA), and statistical analysis was 
performed with STATA (StataCorp, College Station, TX, USA). Continuous variables 
were summarized with descriptive statistics (n, mean, standard deviation) and 
categorical variables were described with counts and percentages. A p-value < 0.05 was 
considered statistically significant. The effect of sociodemographic variables on the 
primary outcome was assessed with multivariate logistic regression analysis. Differences 
of follow-up adherence between patient navigator and the standard of care arms were 
assessed with chi square analysis and odds ratios were calculated. Process variables 
were analyzed in a similar way. Regression analyses (Cox proportional hazard) were 
used to detect differences among navigator group and the standard of care group for the 
time of diagnostic testing. We used a log-rank test to examine differences in the 
distributions of time to first ABR for each group. Corresponding Kaplan-Meier curves 
were used to visualize these distributional differences. Comparison of entrance and exit 
paired data for the study arms was performed with McNemar’s test as well as the 
Generalized Estimating Equation procedure. The data regarding participant knowledge 
of hearing loss involved descriptive statistics (means, standard deviations, frequencies, 
and ranges) and correlational quantitative methods to compare differences between 
study arms. 
 
2.3 RESULTS 
A total of 260 dyads were assessed for eligibility between 2014-2016. The 
Consolidated Standards of Reporting Trials (CONSORT) flow diagram76 demonstrates 
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the subject recruitment enrollment, allocation, follow-up, and analysis (FIGURE 2.2).  Of 
those assessed for eligibility, 197 were unable to enrolled and consented for study 
participation (41 not meeting inclusion criteria, 68 declined to participate, and 88 could 
not be reached by telephone). A total of 63 dyads were enrolled and two participant 
dyads withdrew from the study. A total of 61 dyads were included in the final analysis 
(patient navigator arm = 27 and standard of care arm = 34). The majority of infants were 
born in the University medical center and referred to the University audiology practice 
(n=34) with smaller numbers born outside the University system and referred to the 
University audiology practice (n=15) or born outside the University system and referred 
to a state-funded audiology practice (n=12). The demographic information of parental 
participants is presented in TABLE 2.1. There was a difference in the educational and 
insurance status between the two study arms; however, subgroup analysis within these 
areas revealed no significant difference. There was no significant differences in race, 
age, socioeconomic status, or other demographic factors between the patient navigator 
arm and the standard of care arm. Approximately 28% of the participants reside in rural 
counties and the travel distance to the hearing diagnostic center was significantly greater 
for those participants than those living in urban/suburban counties (61.8 minutes versus 
20.4 minutes, p> 0.001). 
During the first 6 months following birth, adherence to audiological follow-up was 
monitored in all 61 participants and cross-referenced with the EHDI state data registry. A 
significantly lower percentage of participants in the patient navigation arm were non-
adherent to follow up compared to the standard of care arm (7.4% versus 38.2%, 
p=0.005) (FIGURE 2.3); thereby, confirming the hypothesis of this study. According to 
the state registry, those that were non-adherent to follow up in this study did not receive 
any audiological diagnostic care at any facility within the state. Of those from rural 
counties (n=17), none of navigated participants were non-adherent to follow up while 
 
 
FIGURE 2.2: The CONSORT (CONsolidated Standards of Reporting Trials) flow diagram for this study  
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TABLE 2.1 Patient Navigator RCT Study Parental Participant Demographical Data  
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FIGURE 2.3. Non-adherence to audiological diagnostic testing 
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44% of those in the standard of care arm were non-adherent to follow up (p=0.03) 
(FIGURE 2.3).  The timing of the diagnostic appointment was 67.9 days (range 10 – 180 
days) after birth for the navigated participants versus 105.9 days (range 29 - 234 days) 
after birth for the standard of care participants.  The distribution of this time interval 
differed significantly between study arms (p=0.01) (FIGURE 2.4). According to the state 
EHDI registry, one participant in the navigation arm was non-adherent with the 
University audiology practice follow-up, but had follow-up at another audiology practice 
outside of the study sites 10 days after birth. We assessed the effect of variables on 
non-adherence, which included rural residence, distance to diagnostic center, number of 
children in family, race, language, caregiver age, caregiver educational level, household 
income, marital status, child insurance type, family history of hearing loss, 
tobacco/alcohol/illicit drug use during pregnancy. Univariate analysis revealed that 
marital status was the only variable affecting non-adherence with 41% of unmarried 
caregivers non-adherent to follow-up compared with 14% of married caregivers (p=0.02). 
Multivariate logistic regression analysis was then conducted based on this finding and 
when controlling for maternal marital status, participants receiving the patient navigation 
intervention had 83% lower odds of non-adherence than standard of care participants 
(p=0.04).  
During the diagnostic evaluation multiple appointments may be required for a 
variety of reasons (i.e. – rescheduling, failure to follow-up, failure of child to sleep 
through ABR testing, middle ear fluid present) and appointment variables were assessed 
(TABLE 2.2). Navigated participants had a higher average number of attended 
appointments compared with the standard of care participants (p=0.01). Diagnostic 
testing was completed within 3 months in 52% of the entire sample (56% in the 
navigation arm and 48% in the standard of care arm, p=0.57). The timing of a final 
diagnosis was 96.8 days (range 10-236 days) after birth for the 
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FIGURE 2.4. Kaplan-Meier analysis of time (days after birth) to outpatient 
audiological diagnostic testing following failed newborn hearing screening 
(p=0.010). 
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TABLE 2.2. Appointment variables of study participants 
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navigated participants versus 114.7 days (range 29-234 days) after birth for the standard 
of care participants. Four children in the study were diagnosed with congenital hearing 
loss (2 from the navigation arm and 2 from the standard of care arm). These children 
sought care outside the primary institution following diagnosis and no further outcome 
data is available. 
The entrance and exit questionnaire data was available for 43 participants and 
revealed their experiences with the infant hearing assessment process as well as their 
knowledge of recommendations and perception of barriers regarding infant hearing 
healthcare. Approximately 16% of parents did not understand why their child had a 
hearing-screening test in the hospital; however, at the entrance of the study, 98% of 
participants agreed that obtaining follow-up for their child’s hearing was important. 
Regarding outpatient testing, 66% of participants reported that they did not know what to 
expect and 52% reported that they were not knowledgeable regarding the testing 
process. In assessing knowledge of infant hearing loss and treatment, 33% did not know 
the recommended time for infant hearing diagnosis (within 3 months of birth). The 
participants in the patient navigation arm increased in their knowledge of the 
recommendations on outpatient audiological follow up during the course of the study 
(54% correct on entrance versus 78% correct on exit) compared with those in the 
standard of care arm (76% correct on entrance versus 52% correct on exit) (p=0.004) 
(FIGURE 2.5). Overall, the participants reported a high level of confidence with obtaining 
follow-up (97%) at the beginning of the study, which was also reflected on the exit 
questionnaire (100%). At the conclusion of the study, 74% reported that they would be 
comfortable talking about their child’s hearing with others and 98% were willing to 
provide information regarding the hearing testing process to other parents. Multiple 
barriers to obtain follow-up testing were assessed in the entrance and exit 
questionnaires (FIGURE 2.6). 
 
 
FIGURE 2.5. Assessment of participant knowledge of EHDI recommendations regarding timing of audiological diagnostic 
testing and treatment of hearing loss (diagnosis by 3 months and treatment by 6 months of age) at the time of study 
enrollment and exit. 
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FIGURE 2.6. Assessment of participant barriers to obtain hearing assessment at the time of study enrollment and 
exit. 
35 
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Data from the patient navigation intervention were analyzed in 25 of the 27 
participants receiving the intervention and results were compared between rural 
residents and urban residents (TABLE 2.3). Data regarding navigation variables was 
incomplete with 2 participants and this was not included in the analysis. The navigator 
contact with participants occurred primarily over telephone calls, but some 
communication occurred through mobile phone texting. Contact with patient navigation 
participants was complicated by inactive mobile phone service (monthly minutes cellular 
phone plans) or disconnected numbers. Patient navigation satisfaction was also 
assessed at the conclusion of the study and the intervention was rated highly (TABLE 
2.4). 
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TABLE 2.3. Patient navigation intervention variables 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE 2.4. Patient navigation satisfaction data  
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2.4 DISCUSSION 
Pediatric hearing loss constitutes a major public health problem and delayed diagnosis 
can lead to life-long communication deficits. Early identification and treatment of infant 
hearing loss is essential but unfortunately delayed in many children.13-15 This research 
addresses a significant gap in the field of early hearing diagnosis and intervention 
research. There is no literature that addresses the efficacy of initiatives designed to 
decrease non-adherence in follow-up after infant screening for diagnosis or hearing loss 
intervention. Contact with parents after infant hearing screening may influence follow-
up.31 Parent-to-parent programs, such as Guide By Your Side,32 are available in many 
states and may reduce parental isolation and boost parental acceptance of the child’s 
condition.22 Current programs typically require the parents to make initial contact to 
establish services and often are not utilized until a diagnosis of hearing loss is made. No 
previous studies have examined the use of a patient navigator following infant hearing 
screening; however, navigation is an intervention model that is well suited to address 
non-adherence. The original concept and development of this intervention stems from 
the findings of the American Cancer Society National Hearings on Cancer in the Poor in 
1989 and the subsequent work of Dr. Harold Freeman to develop the first patient 
navigation program to promote timely cancer treatment in the inner city of New York.
53 
Since that pilot program, many cancer centers have been using patient navigators to 
improve the quality and timeliness of care This study demonstrated a decrease in the 
lost to follow-up rates in participants that received the patient navigation intervention 
after discharge from the hospital compared with the standard of care arm of the study. In 
spite of a small sample of rural participants, the intervention was similarly efficacious in 
rural residents. Randomization in study arm allocation helps to strengthen the validity of 
the findings. 
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Many efforts are underway in EHDI programs nationwide to improve infant 
hearing testing. Screening tests such as automated ABR and OAE have many false-
positive results that lead to medical staff and parents dismiss and devalue the screening 
results and the importance of definitive adherence of infant.17 Double screening while in 
the newborn nursery is currently being investigated to decrease the false positive rate. 
Further efforts to improve adherence include hospital scheduling of outpatient testing 
and more effective communication with primary care physicians. Better communication 
between EHDI programs and primary care physicians may also improve adherence rate. 
This will provide additional opportunities to educate providers on the importance of 
timely infant hearing assessment.  Many factors and barriers complicate timely access to 
healthcare. Misinformation, inconsistent care, cultural or health beliefs, socioeconomic 
status, mistrust of the healthcare system, and lack of social support influence non-
adherence within healthcare.51 Within the EHDI field, factors complicating access to care 
include poor communication of hearing screening results, difficulty in obtaining outpatient 
testing, inconsistencies in healthcare information from primary care providers, lack of 
local resources, insurance-related healthcare delays, and conflict with family and work 
responsibilities.77 Addressing these barriers to care is complicated and may require 
multiple approaches. Families of children with hearing loss report that they lack 
confidence and resources needed for healthcare decision-making for their child.22 
Parents of children with hearing loss also lack role models who have been through the 
complex process of hearing loss diagnosis and intervention.22 In previous research, 
prenatal educational modules29 and social worker counseling30 have not demonstrated 
significant benefit in promoting rescreening after a failed infant hearing screening. The 
personalized patient support and continuity of education and assistance may 
differentiate patient navigation from other care coordination models. This method of 
educating patients through patient navigation may be a potential mechanism for 
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improved adherence with testing in this population, as there was evidence in this study 
of an improved knowledge base in navigated participants regarding EHDI hearing 
assessment and treatment recommendations. Navigation also has the potential to 
address multiple personal and external barriers that prevent adherence and access to 
care. A small percentage of the participants in this study reported on barriers to obtain 
infant hearing assessment; however, there was a trend toward a decrease in insurance 
barriers and home responsibilities barriers in the navigated patients at the conclusion of 
the study. A sampling bias is present in barrier assessment in this study as there is a 
lack of data from those that were lost to follow up and the responses of those 
participants would likely be informative. Further research is needed to capture data 
regarding barriers on those lost to follow up which may employ participant interviews to 
identify barriers to care.  
Patient navigation has been successfully implemented within the oncology field 
to improve access to care in underserved populations and overcoming barriers to their 
care. A variety of types of navigators has been reported and may include lay people 
who have had personal experience with the disease and represent the population they 
were serving.62 Others have reported using professional health care workers66 or social 
workers64 to perform navigation activities. Bilingual navigators may further improve 
adherence with non-English speakers.68 The structure of a navigation intervention may 
involve a highly structured guide or assessment tool or an informal discussion of barriers 
to care.59,64-67 Within the field of oncology, navigators have assisted patients in 
overcoming obstacles such as lack of transportation, lack of insurance, poor 
coordination of healthcare appointments, language barriers, and limited healthcare 
literacy.59,64,67 The timing of navigation is also associated with the success of such a 
program67 as navigation is more effective if it is initiated shortly after an abnormal 
screening test and may increase adherence with obtaining definitive diagnostic testing. 
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The implementation and sustainability of patient navigation within infant hearing 
healthcare is dependent on cost. There is a lack of cost assessment of patient 
navigation within established oncology navigation programs; however, one such 
program reported an increase in cost of $275 per patient with patient navigation 
compared with the control group during the course of screening testing leading to 
diagnostic testing.66 The cost of a patient navigation program within EHDI programs is 
unknown and deserves further study. Method of intervention delivery also deserves 
further attention, as it may be possible to deliver patient navigation through remote 
access or telehealth link. Telemedicine may also allow connection of patients to 
providers; however, consistent delivery of infant hearing diagnostic testing can be 
complicated by cost and fidelity of testing. Telemedicine may also be a means to 
education caregivers and audiologists in remote areas to improve efficiency and 
accuracy of infant diagnostic hearing testing. Further research is needed on cost 
assessment and cost effectiveness of telemedicine interventions and other interventions 
developed to expand access to care. 
This study was complicated by difficulty in recruiting all eligible study participants. 
When evaluating potential participation into the study, 68 parents did not wish to 
participate, primarily due to concerns with randomization in study arm allocation. Most of 
these parents expressed concern and did not wish to be randomized into the control 
group as they wished to receive every possible resource to aid in their child’s hearing 
testing follow-up. Others expressed concern over being enrolled in a research study, as 
they perceived they might receive substandard care. In spite of careful explanation of the 
study, these 68 did not wish to participate. A concerning number of participants (N=88) 
were potentially eligible for the study; however, they could not be contacted by phone. 
Most of these potential participants had provided mobile cell numbers; however, when 
research staff attempted to contact these individuals their phone usage minutes had 
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been maximized or the number was no longer in service. Most participants did not 
provide alternative numbers; therefore, we were unable to contact them. Some of these 
patients may have been discharged from the primary University recruitment site during 
evenings or weekends and were not visited by study staff while in the hospital. 
Adjustments were made to recruiting methods to prevent the loss of these participants. 
Most of the 88 parents were referred to a facility outside the main university and there 
was no direct contact between that clinic, the university, or the research staff. This group 
of parents is an important subset of patients that need further research and attention. 
Parents that leave a small birthing hospital and are not given follow-up appointments 
and cannot be contacted by phone are at a significant risk for non-adherence. Additional 
uncontrolled variables and design limitations to this study may limit the generalizability of 
the findings. Since these participants were never contacted, informed consent was not 
obtained and we are unable to investigate the status of follow-up or outcomes of this 
group. It may be possible to increase recruitment among participants such as these by 
sending study information documents to the home address of these participants. By 
partnering with state EHDI system, it may be also possible to increase recruitment by 
sending study information to the primary care physician caring for that newborn. 
Connecting with the parents who were not enrolled initially into the study could provide 
valuable information regarding knowledge, attitudes, and behaviors regarding infant 
hearing testing adherence. Increased efforts to contact the parents prior to discharge 
may also bear fruit. 
 Attention bias is a potential limitation of this study as the intervention group may 
have had improved adherence to follow-up due to increased contact alone while the 
standard of care group had less contact and thus had poorer adherence. While this was 
not directly controlled for in this efficacy study, other studies that have had increased 
contact with parents through prenatal educational modules32 and social worker 
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counseling30 has not demonstrated significant benefit in promoting rescreening after a 
failed infant hearing screening when compared with control groups. The mechanism 
behind the efficacy of navigation delivery is unknown and further research, through 
mixed quantitative and qualitative methods, is needed. Another potential limitation 
includes selection bias with differences in the demographics of the study samples. 
These differences could influence the results (i.e. overall educational level and insurance 
status); however, subgroup analyses within these areas reveal no significant differences 
and household income is similar between the two study arms. An additional factor that 
could influence the outcomes of this study involves the type of education and level of 
communication provided in different birthing hospitals (prior to enrollment). 
Randomization in the study design may decrease the influence of this factor; however, 
there remains significant variability in the teaching provided directly by healthcare staff 
(or lack thereof), as well as, the educational resources provided to parents of infants who 
fail newborn screening. An additional limitation includes a lack of long-term follow up and 
assessment of the effect of patient navigation on timing of treatment for those diagnosed 
with hearing loss in this study. Finally, this study was limited in that a single parent or 
caregiver was targeted for the intervention; however, other caregivers (grandparents or 
other family members) may be vital targets for navigation and further research is needed 
to assess the role of other care providers in adherence to outpatient diagnostic testing.   
Patient navigation is a promising intervention to promote adherence to infant 
hearing assessment following failed screening. Further work is needed in this field to 
assess, through multivariate analysis, key factors that influence non-adherence with 
testing. By identification of the key factors in non-adherence, navigation may be modified 
and customized to target those factors to maximize appointment adherence. The method 
of navigation intervention delivery is an area for future research as well. The lack of 
consistent phone service in lower socioeconomic groups is a significant barrier to 
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communication in healthcare, which also complicated patient navigation in this study. In-
person delivery of navigation could help address this communication gap. Home visits 
with participants would be a potential method to increase the strength of the patient-
navigator relationship. Development and implementation of a community-based 
navigation program that will monitor long-term hearing outcomes may have greater 
reach into remote areas to educate and support these patients. Further research is 
needed to investigate the effectiveness of patient navigation on a larger statewide level 
and investigate that implementation factors that enable patients to successfully 
navigation the hearing healthcare system. Additionally, assessment of the cost of patient 
navigation may influence the likelihood of integrating it into state EHDI programs. 
Performing cost-benefit analysis of patient navigation in the future will require long-term 
assessment of speech and language outcomes along with costs associated with 
rehabilitation and education of children with hearing loss.  
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CHAPTER THREE: HELPING INFANTS GET HEARING RESOURCES: THE HIGHER 
PATIENT NAVIGATOR TRIAL 
 
3.1 SPECIFIC AIMS 
As the most common neonatal sensory disorder, infant hearing loss has an 
incidence of at least 1.6 per 1000 births.1 Early childhood hearing loss that is not 
identified and treated appropriately usually results in significant delays in language, 
cognitive, and social development,2 with profound later effects on education and 
employment.3 The economic costs of hearing loss are substantial; the overall lifetime 
medical, educational, and occupational costs due to deafness are estimated to be $2.1 
billion.4 The U.S. Preventive Services Task Force (USPSTF) reported that early 
detection and intervention of infant hearing loss decreases speech impairment, 
social/emotional challenges, and learning/behavioral disorders.5-7 The Joint Committee 
on Infant Hearing (JCIH) recommends that all infants be screened before 1 month of 
age, diagnosed before 3 months of age, and initiate treatment before 6 months of age 
(often referred to as the “1-3-6 rule”).12 
Early infant hearing detection and intervention (EHDI) programs are coordinated on 
a state level; however, non-adherence to diagnostic testing after failed newborn 
screening is a national problem. EHDI programs aim to have 90% of U.S. infants with 
failed infant hearing screens tested and diagnosed within 3 months of failed screening, 
but fall unacceptably short: only 41.1% meet that standard.1 Heightening the concern for 
life-long complications due to delayed diagnosis following a failed newborn screening, 
the outpatient diagnostic and hearing loss treatment process is complex and difficult for 
parents to navigate.16 Families of children with hearing loss are often uninformed 
regarding the EHDI process and lack peer support in obtaining care for their child.21,22 
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Similar problems in cancer care have been addressed with patient navigation (PN) 
programs, leading to improved adherence to recommended diagnostic testing after 
abnormal screening and resulting in improved patient care and healthcare system cost 
savings.45,50,64 Patient navigators (PNs) are trained healthcare workers who assess and 
mitigate personal and environmental barriers to promote healthcare adherence and 
improve access to care.34  
We have recently conducted a randomized controlled efficacy trial of PN in 
collaboration with the Kentucky EHDI program and have demonstrated significantly 
decreased infant hearing diagnostic testing non-adherence (7%) compared to the 
standard of care (38%)(p=0.005). However, PN has yet to be tested or systematically 
implemented within state EHDI programs. Further, there is a major gap in the hearing 
healthcare field regarding effectiveness and implementation research on interventions 
designed to decrease infant hearing diagnostic non-adherence.33 To address this 
significant gap in research and practice, an effectiveness trial of PN coupled with 
implementation research would inform its potential scale-up to maximize public 
health impact. The proposed research is a type 2 hybrid effectiveness-implementation 
trial78 of a PN intervention aimed at decreasing infant hearing diagnosis non-adherence 
after failed newborn hearing screening, delivered in 10 state-funded EHDI program 
clinics. This design allows for simultaneous assessment of the effectiveness of a clinical 
intervention, while comparing implementation methods. Using a stepped wedge design, 
we will:  
 
Specific Aim 1: Test the overall effectiveness of PN to decrease non-adherence to 
receipt of infant hearing diagnosis within 3 months after birth. Hypothesis: PN will 
decrease non-adherence to obtaining infant hearing diagnosis within 3 months after birth 
compared to the standard of care. In Aim 1, effectiveness of PN to decrease clinic-level 
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non-adherence rates will be tested via comparison to non-adherence rates during the 
standard of care condition.  
 
Specific Aim 2: Explore associations among implementation factors, 
implementation outcomes,79 and effectiveness outcomes. Research questions: (a) 
What are the associations of inner clinic setting characteristics (I.e. - clinic resources, 
clinics’ need for change, clinic culture, clinic readiness for implementation), outer clinic 
setting characteristics (patient needs and resources, external policy and incentives), and 
PN characteristics with adoption, recruitment/retention, reach/penetration, and 
sustainability? (b) How does PN modality—local or centralized—affect clinic-level non-
adherence rates? Aim 2 will employ mixed methods to provide valuable information 
regarding key factors associated with implementation and effectiveness outcomes. 
 
Specific Aim 3: Determine the cost-effectiveness of PN from the perspective of 
third party payers. Hypotheses: (a) PN via either local or centralized delivery will be 
cost-effective compared to the standard of care from the perspective of third-party 
payers; (b) Centralized PN will be as or more cost-effective as local PN. In Aim 3, net 
costs and net effectiveness of PN will be compared with standard of care. 
 
This study is significant because it aims to reduce non-adherence to timely infant 
diagnostic hearing testing to prevent life-long negative consequences. It harnesses our 
research team’s existing collaborations and expertise in addressing hearing healthcare 
disparities with culturally appropriate interventions. This research is innovative in testing 
an intervention not previously assessed in hearing healthcare within a state-funded 
EHDI program, and in integrating implementation research and cost-effectiveness 
methods with our effectiveness aim. Our results will impact the field by informing 
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potential scale-up of this and other innovative patient supportive interventions to create 
efficient and effective EHDI programs and maximize public health impact. 
 
3.2. SIGNIFICANCE 
3.2.1: The Importance of Assessing PN Effectiveness and Implementation Factors 
For PN to be scaled up to maximize public health impact, effectiveness trials 
must be coupled with implementation research. A key challenge in implementing any 
evidence-based program is understanding and addressing the multilevel factors 
influencing the success (or lack thereof) of whether and how an intervention is delivered. 
There is no research or clinical standard in hearing healthcare to guide the development, 
scope, or delivery of programs to reduce non-adherence. However, state-funded EHDI 
programs provide infrastructure within each state to assess and track hearing in young 
children, providing an ideal platform for the delivery of PN targeting infant hearing testing 
and treatment. EHDI programs have the capacity to target the most vulnerable patient 
populations (e.g., low levels of parental education, low socioeconomic status, public 
insurance), who are also at highest risk for non-adherence with recommended 
diagnostic testing.15,17-20 In Kentucky, audiology clinics serving EHDI patients are 
administered by the Kentucky Commission for Children with Special Health Care Needs 
(CCSHCN). By partnering with EHDI and CCSHCN to conduct this research, we can 
assess not only effectiveness of PN, but also implementation factors, outcomes, and 
costs expended/averted in the settings intended to reach the most vulnerable patient 
populations in our state.  
3.2.2: The Project Goal 
The overarching goal of the proposed research is to conduct a type 2 
hybrid effectiveness-implementation trial78 of a PN intervention aimed at 
decreasing infant hearing diagnosis non-adherence after failed newborn hearing 
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screening, delivered in state-funded EHDI clinics. Hybrid designs in implementation 
science offer rigorous and efficient approaches to simultaneously assess the 
effectiveness and implementation of interventions and programs delivered in community 
settings and thus are ideal for the proposed project.78 Type 2 hybrids directly blend 
clinical effectiveness and implementation research aims toward more rapid translation to 
practice. Effectiveness, implementation outcomes, implementation factors, and cost-
effectiveness of PN will be assessed. 
3.2.2: Summary of Significance  
The scientific premise of the proposed study is based on our own and others’ 
research showing that: 1) delayed diagnosis of pediatric hearing loss has profound life-
long negative effects, yet non-adherence rates for diagnostic testing are unacceptably 
high; 2) there is a pressing need for a scale-able evidence-based approach to address 
this public health problem; 3) PN is efficacious to reduce non-adherence to infant 
hearing diagnostic testing, but lacks effectiveness evidence; and 4) understanding of 
implementation factors and cost-effectiveness of PN are critical to potential scale-up of 
this intervention. Our findings will directly inform state-level policy and services impacting 
children with hearing loss and set the stage for a national multi-site implementation trial 
and potential scale-up to maximize public health impact. 
 
3.3 INNOVATION  
3.3.1: Investigating PN delivered within state-funded clinics is a novel step forward in 
developing efficient, effective, and scale-able EHDI programs.  
PN is an ideal intervention model to implement in the field of hearing loss 
because it is evidence-based and distinct from existing programs in hearing healthcare 
and EHDI settings. As demonstrated in the cancer field, PN can be effectively delivered 
and scaled-up to a broader level. EHDI programs do not have an evidenced-based 
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standardized program that addresses non-adherence to diagnostic testing in infants; PN 
has the potential to fill this gap and could become a national standard in EHDI programs. 
3.3.2: An evidence-based preventive intervention targeted to parents/caregivers of 
infants immediately after abnormal screening is a novel strategy to improve EHDI 
system efficiency.  
This intervention differs from other EHDI parent support programs (i.e., Guide by 
Your Side) because it is integrated into the referral to the EHDI program and support is 
provided before the scheduled diagnostic testing appointment. Other programs (i.e., 
Guide by Your Side and tele-audiology) require families to voluntarily seek support and 
typically occur after the diagnosis of hearing loss, which may be delayed. Delivery of PN 
shortly after abnormal screening, rather than at the time of follow-up/diagnosis, could 
improve the efficiency of EHDI and expedite pediatric hearing loss diagnosis and 
treatment. 
3.3.3: The utilization of a type 2 hybrid effectiveness-implementation study using a 
stepped wedge trial design is innovative in this field.  
This study allows for multilevel intervention and analysis of clinical effectiveness 
and implementation outcomes at the clinic level and the patient level. Given the positive 
results of our preliminary efficacy trial, the pragmatic stepped wedge design is preferred 
to a randomized controlled trial design due to ethical and feasibility concerns,80 while still 
allowing rigorous design and robust evaluation. This study design is unique in the field of 
pediatric hearing loss and would significantly advance the field.  
3.3.4: The delivery of preventive interventions to high risk and underserved communities 
is often overlooked but is an essential component of this research.  
 Disparities in underserved populations are a NIDCD priority area.81 However, no 
intervention studies have targeted rural pediatric hearing loss and hearing healthcare 
disparities. This proposal is responsive to and innovatively addresses the NIDCD 
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Strategic Plan Priority Area 4, focused on increasing access to health care and 
enhancing delivery of care.81 
3.3.5: The cost analysis component of this study will use a novel simulation modeling 
approach that accounts for multi-site variation at both the individual patient level and 
programmatic level.  
This will allow us to provide cost-estimates of PN, and more importantly, provide 
evidence about the economic feasibility of implementing PN on a larger scale. 
 
3.4 APPROACH 
3.4.1 Overview 
We propose a rigorous, type 2 hybrid effectiveness-implementation trial testing a 
PN intervention to reduce infant hearing diagnosis non-adherence after failed newborn 
hearing screening. Using a stepped wedge trial design, PN will be implemented 
sequentially in each of 10 state-funded Kentucky CCSHCN clinics randomized to cross 
from usual care to PN in steps of 6-month intervals over the project period (Aim 1). Prior 
to initiation of PN at each clinic, the control condition will be the standard of care. The 
overall effectiveness of PN will be tested by comparing non-adherence rates during the 
PN condition to those during the standard of care condition. We will also assess key 
factors associated with implementation outcomes at each clinic (Aim 2), including 
potential effects of using centralized versus local PNs. Finally, we will determine the 
cost-effectiveness of PN from the perspective of third party payers, using a novel 
simulation modeling approach accounting for multi-site variation at both the individual 
patient level and programmatic level (Aim 3). Successful completion of our aims will 
inform EHDI programming to (1) reduce infant hearing diagnosis non-adherence, (2) 
facilitate development of a multi-state implementation trial of PN to further support scale-
up, and (3) contribute to the developing field of implementation science. Our highly 
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collaborative interdisciplinary research team has collective expertise in hearing 
healthcare disparities, behavioral clinical trials, community-engaged research, 
implementation science, and health economics/health policy. We are uniquely positioned 
to conduct this project with our existing collaborations, the support and engagement of 
strong research partnerships with Kentucky’s CCSHCN and its EHDI program, our 
network of audiologists and hearing healthcare providers across the state, and 
outstanding consultants providing support for each aim.  
 
3.4.2 Pilot Studies 
1. The complexities of the EHDI system influence timing and access to care in 
largely rural states. This transdisciplinary research team has recently completed a 
series of studies documenting:  
a. Delayed treatment results from infant hearing testing non-adherence 
following newborn hearing screening in rural communities: In a retrospective 
review of 2009-2011 state EHDI data, we have found that infant hearing loss occurs 
in 1.7 of 1000 live births in Kentucky.13 Of those with failed newborn hearing 
screening, 27% of children born in rural regions were non-adherent to obtain 
diagnostic testing.13 Children from rural areas were also delayed in intervention.14,15 
b. Primary care physicians face barriers to promote EHDI initiatives: In a cross-
sectional survey of 93 rural physicians, many providers reported that they do not 
receive newborn hearing screening results consistently and they lack confidence in 
counseling parents through the EHDI process.82 
c. Lack of parental knowledge and support to navigate the EHDI system: In 
quantitative and qualitative studies investigating parental knowledge, attitudes, and 
behaviors regarding the EHDI system, more than 20% of parents found the process 
of newborn hearing testing difficult, and many were unaware of the screening 
 
 54 
results and need for follow-up at the time of hospital discharge.17 Misinformation 
from providers and difficulty coordinating appointments were prominent barriers to 
infant hearing testing.77 
Importantly, the state EHDI program is the only entity to follow up on outpatient 
testing; thus, successful collaboration with the EHDI program and CCSHCN clinics is 
essential. In each of the above studies, close collaboration with our state EHDI 
program was crucial. These studies demonstrate the expertise and history of 
collaboration among the PI, co-investigators, and the EHDI program and 
CCSHCN clinics in investigations of the causes and effects of infant diagnostic 
hearing testing non-adherence.  
2. PN is Efficacious in Promoting Timely Infant Hearing Healthcare. We have 
recently conducted a randomized controlled clinical trial (N = 63) with parents of 
infants with abnormal newborn hearing screening. Dyads who were referred for 
audiological diagnostic testing were recruited from an academic hospital birthing 
center within the first week after birth and randomized to PN or standard of care. 
Receipt of diagnostic testing was monitored for 6 months after enrollment and the 
non-adherence rates and timing of diagnostic testing were compared between 
groups. Significantly fewer participants in the PN arm were non-adherent to follow-up 
testing compared to standard of care (7.4% vs 38.2% overall, p=.005; 0% vs 44% 
among rural participants, p=.03). Timing of the diagnostic appointment was 67.9 days 
(range 10-180 days) after birth for PN participants versus 105.9 days (range 29-234 
days) for standard of care (p=0.01). PN participants increased knowledge of 
diagnostic testing recommendations (54% correct on entrance versus 78% correct on 
exit) compared with those in the standard of care arm (76% correct on entrance 
versus 52% correct on exit) (p=0.004). This study was conducted in collaboration 
between UK and several CCSHCN clinics, and demonstrates (a) the expertise of 
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the investigative team in conducting clinical trials involving PN in this 
population; (b) justification for studying effectiveness and implementation of 
PN; (c) feasibility of the proposed project; and (d) successful collaboration with 
our state and community partners.  
3. PN Procedures are Feasible and Acceptable but Require Flexibility. Analyses of 
process data from the PN arm revealed that while PN contact with participants 
occurred primarily over telephone calls, some communication occurred through 
mobile phone texting. Contact was sometimes complicated by inactive mobile phone 
service or disconnected numbers, suggesting that facilitating multiple modes of 
contact (including in-person) could increase uptake of the program. Patient 
satisfaction with PN was also assessed at the conclusion of the study and the 
intervention was rated highly by parents. This study demonstrates the expertise of 
the investigative team in assessing PN feasibility/acceptability and lays the 
groundwork to assess different implementation strategies in this population. 
 
3.4.3. The PN Intervention 
PN is widely effective in other complex healthcare fields, as well as accepted and 
effective among rural and low socioeconomic status populations. PNs are trained 
individuals who assess and mitigate personal, interpersonal, and environmental barriers 
to healthcare adherence, consistent with the tenets of SCT24-27 toward promoting healthy 
behaviors. Our PNs will work with participants to identify and address specific barriers to 
obtaining follow-up diagnostic hearing testing for their infants, provide social support via 
supportive listening, provide educational materials, and provide referrals for additional 
assistance, if needed.75 PNs will provide instrumental assistance by helping participants 
make appointments, resolve child-care problems, and address transportation issues.83 
PN selection criteria and training will be in accordance with a widely accepted 
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model established by the National Cancer Institute Patient Navigator Research Program 
and the American Cancer Society Patient Navigation Program.74 Potential PNs will be 
identified from an existing pool of parents/patients who have requested to be involved in 
hearing healthcare research and patient advocacy maintained by Kentucky’s CCSHCN 
(see C.6.a for details). At least one bilingual (Spanish-English) PN will be recruited for 
each site. All PNs will complete a 3-week curriculum involving:  
1) Standardized PN Training: PNs will complete the training and fidelity standards set 
by a National Patient Navigator training program.74 It is important to establish that 
there is currently no subject-specific standard protocol for PN for families in the EHDI 
system; thus, our PN efficacy trial guided content development of our training 
protocol. The positive results of our efficacy trial support our PN curriculum. 
2) Audiology/EHDI System Training: PNs’ audiological training will be directed by Dr. 
Shinn, who serves as the co-chair of the Kentucky EHDI advisory committee and has 
extensive knowledge of audiological resources across the state. Initial audiological 
training will involve three hours of formal lecture covering the process of diagnosing 
and treating infants with congenital hearing loss. These will be supplemented by 
appropriate and relevant readings (i.e., JCIH 2007 Position Statement12), adjusted to 
a sixth grade reading level. Our consultant Dr. White serves as the director of the 
National Center for Hearing Assessment and Management (NCHAM) and will provide 
further resources for PNs from the NCHAM website (www.infanthearing.org).84 
Finally, PNs will participate in 8 hours of experiential training in which they will 
observe live patient encounters, testing equipment/procedures, and clinic procedures, 
including scheduling. 
3) Patient Communication Strategies and Resource Development: Using resources 
from a national PN collaborative (http://patientnavigatortraining.org),85 PNs will be 
trained in communication strategies, developing community resource maps, 
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interviewing skills, conflict resolution, and professional boundaries. 
 
Navigator intervention delivery will follow the American Cancer Society PN model.74 
Navigation will be delivered through either local PNs (parents from the same geographic 
region as the clinic) or centralized PNs (parents at the PI’s institution; see C.4 and C.6 
for details). PNs will seek to identify parent needs, connect parents to community and 
social support services, facilitate interaction and communication with healthcare staff 
and providers, and provide health education, all toward the goal of obtaining diagnostic 
hearing testing for their infant. PNs will contact parents by telephone for an initial 
interview, building rapport and assessing needs and resources. PNs will then contact 
parents weekly using the parent’s preferred method (phone or text – local and 
centralized PNs; in-person visits – local PNs only). Weekly PN contacts will continue 
until the diagnostic test has been obtained (verified by EHDI data) or until 12 weeks 
since birth have elapsed, whichever occurs first. 
 
3.4.4 Overall Study Design  
We propose a rigorous stepped wedge randomized prospective trial to achieve 
our 3 aims investigating the (1) effectiveness, (2) implementation, and (3) cost-
effectiveness of PN versus standard of care in reducing infant hearing diagnosis non-
adherence after failed newborn hearing screening.  
The state-level EHDI and CCSHCN are our partners in this research, and we 
have existing collaborations with audiologists and staff at all of their clinic sites. 
CCSHCN has agreed to engage 10 of their 11 clinics in this study. (The number of 
infants referred annually to the 11th clinic is <16, making it inappropriate for this study.) 
The Kentucky EHDI Advisory Board has also fully supported this study.  
The 10 participating clinics represent a cross-section of the Kentucky population 
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with urban and rural settings and are located in Knox, Warren, Hardin, Perry, Fayette, 
Rowan, McCracken, Floyd, Pulaski and Jefferson counties (FIGURE 3.1). These clinics 
provide 500-600 diagnostic hearing tests per year following failed newborn nursery 
screening, but not all meet the 1-3-6 rule. An additional ~100 referrals are made to each 
clinic each year that do not result in diagnostic testing. Overall, of all referred infants, 
25.9% are non-adherent to diagnostic follow-up testing within 3 months of birth. 
Under a sequential rollout in steps of 6-month intervals, the 10 clinics will be 
randomly allocated to implement PN over the project period (FIGURE 
3.2). Randomization will be stratified by clinic patient population size and conducted by 
our study biostatistician, Dr. Westgate. The highly pragmatic stepped wedge trial design 
will allow all clinics to contribute control group data as well as intervention data. Note 
that during the first 6 months of the project, all 10 clinics will be in the control condition. 
The first clinic will cross to the intervention condition following month 6 of Y1, and the 
10th clinic will do so following month 6 of Y4 of the project period. PN delivery will 
continue through the first half of Y5. 
Additionally, clinics will be randomly allocated to either local or centralized PN by 
Dr. Westgate. Based on our preliminary feasibility and acceptability results (see pilot 
study (c) under C.2), combined with our previous work in cultural adaptions and delivery 
of parent-focused interventions in rural Appalachian communities,86 local PNs may be 
more acceptable to parents than centralized PNs. Including two intervention modality 
conditions will allow investigation of this implementation factor in Aim 2. 
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FIGURE 3.1 : Number of Unique Infant Hearing Diagnostic Tests per CCSHCN 
Clinic 
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FIGURE 3.2: Stepped Wedge Trial Design 
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3.4.5. Aim 1 Methods: Test the effectiveness of PN to decrease non-adherence 
to receipt of infant hearing diagnosis within 3 months after birth compared to 
standard of care. 
Aim 1 Study Sample and Recruitment 
Clinics: The 10 participating clinics are described above under 3.4.4. 
Parent-Infant Dyads: Given the referral data described in 3.4.4, we anticipate ~1700 
referrals to the 10 clinics during their time in the PN intervention condition (i.e., an 
average of 68 referrals per year per clinic, with clinics randomized to receive PN for 
periods spanning 1 to 4 years). In our efficacy trial, 84% of all referred dyads were 
eligible. Thus, we anticipate ~1400 eligible infant referrals to the clinics while in the PN 
condition, and we aim to enroll 80% of all eligible dyads (N=1120 dyads). Inclusion 
criteria include: 1) Parents whose infants fail hearing screening in one or both ears 
before postnatal hospital discharge, 2) whose infants are referred for follow-up 
diagnostic testing at one of the 10 participating CCSHCN clinics, and 3) who are ages 18 
and older. Exclusion criteria include: 1) Infants hospitalized past 30 days after birth, 2) 
parents who live outside Kentucky or will be moving out of state within the infant’s first 3 
months of life, or 3) infants who are wards of the state.  
Once a clinic crosses from standard of care to PN in the stepped wedge design, 
recruitment of all eligible parent-infant dyads in that clinic will begin. Prior to postnatal 
hospital discharge, parents whose infants fail their newborn hearing screening test are 
referred to university-based, private, or CCSHCN hearing centers for follow-up testing. 
The referral and contact information for these parents is collected and maintained by the 
state EHDI program. Within one week of postnatal hospital discharge, research 
personnel will contact by phone each parent referred to a clinic in the PN condition to 
describe the study, screen the parent-infant dyad for eligibility, and invite eligible dyads 
to enroll in the study. Informed consent will be obtained over the phone and will include 
permission from parents to access their infant’s hearing data from EHDI.  
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Aim 1 Procedures 
Clinics: All data collected on non-adherence to follow-up within 3 months after birth will 
be at the clinic level. The primary effectiveness outcome is the proportion of non-
adherent referrals for diagnostic testing at each clinic during each month of the trial. 
Clinic-level data will be compiled on a monthly basis by CCSHCN co-investigator Cathy 
Lester. The effectiveness of PN (regardless of local versus centralized) to decrease non-
adherence rates will be compared to the standard of care condition. 
Parent-Infant Dyads: Within one week of study enrollment, a trained research assistant 
will administer by phone baseline measures of knowledge of hearing loss, self-efficacy 
for obtaining follow-up testing, and real and perceived barriers in obtaining follow-up 
testing. In the event of an non-operational phone, the participant will be mailed the 
baseline measurement questionnaire which will be returned in a stamped return 
envelope. Following completion of baseline measures, parents will be contacted by the 
PN to initiate intervention delivery as described in C.3.b above. Post-test measures will 
be administered by phone by a research assistant 16 weeks after birth; the research 
assistant will not have access to data regarding parents’ follow-up with diagnostic 
testing. Parent participants will be compensated $20 for each set of completed 
measures (i.e., at baseline and at post-test assessment).  
Measures: Secondary effectiveness outcomes include parent participants’ knowledge, 
self-efficacy, and barriers regarding obtaining follow-up diagnostic testing for their infant. 
Parent knowledge will be assessed using 4 multiple-choice items on diagnostic testing 
purpose and recommendations. These items were developed in our preliminary RCT 
and yield knowledge scores from 0-4. Parent self-efficacy to obtain diagnostic testing 
for their infant will be measured using a 10-item self-efficacy scale adapted from an 
existing measure examining self-efficacy to obtain cancer screening.87 Each item uses a 
5-point Likert-type response scale and addresses one step associated with the process 
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of obtaining testing (e.g., making an appointment, transportation, payment, proceeding 
when worried, and others). Scores range from 10 (low self-efficacy) to 50 (high self-
efficacy). Parent-identified barriers will be measured using five items with 5-point 
Likert-type response options. The items tap barriers to obtaining diagnostic testing 
identified by parents in our preliminary studies,17,77 and scores range from 5 (minimal) to 
25 (many). We will obtain EHDI clinic data for all enrolled infants until their one-year 
birthday (or until data collection ends) to determine the time from birth to initial 
completed outpatient hearing assessment, number of no-show appointments, and 
number of rescheduled appointments.  
 
Aim 1 Analyses 
All tests will be two-sided and will use a 5% statistical significance level. Analyses will be 
conducted in SAS version 9.4 (SAS Institute, Cary, NC). Secondary analyses will utilize 
adjusted significance levels or p-values to control for Type I errors due to multiple testing 
using the method of Benjamini and Hochberg88 to control the false discovery rate, which 
is an alternative to, and more powerful than, the conservative Bonferroni correction.  The 
primary effectiveness outcome is non-adherence rate, obtained with clinic-level data. 
Analysis methods must account for any clustering within clinics (i.e., statistical 
correlation among the binary non-adherence outcomes from patients within the same 
clinic). Therefore, the primary intent-to-treat data analysis will utilize generalized 
estimating equations (GEE) with corrected empirical standard errors in order to maintain 
valid inference.89 We will fit the commonly utilized logistic regression model for the 
analysis of binary outcomes arising from a stepped wedge design with clinics.90 
Specifically, fixed effects for trial condition (primary interest) and time (nuisance 
covariates needed to ensure a valid model) will be included in the model. Due to the use 
of a stepped wedge design, clinics serve as their own controls, thus reducing the 
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possibility of having a lack in balance between trial arms. For all analyses, 
recommended statistical approaches will be utilized in the presence of missing data 
(e.g., multiple imputation at the cluster level).  Sensitivity analyses will be considered 
and dictated by the type(s) of missing data.  
Consistent with NIH requirements for rigor and transparency, secondary 
analyses will include important sociodemographic variables (including sex of parents and 
infants, parental age, parental educational attainment, household income, rural 
residence) as covariates within the above model. Regarding additional secondary 
outcomes of interest, we will explore associations among parent knowledge, self-
efficacy, and barriers as related to (a) non-adherence, (b) time interval from birth to the 
initial completed outpatient ABR, (c) number of no-show office visits, and (d) number of 
rescheduled visits. Each of these analyses will utilize the same general GEE approach 
to account for clustering of outcomes from participants in the same clinic. Depending on 
the outcome type, a marginal (population average interpretation) generalized linear 
model will be fit (i.e., a linear model for a continuous outcome and logistic model for a 
binary outcome). 
 
Aim 1 Power and Sample Size Calculations 
The trial follows a stepped wedge design consisting of data collection from 10 clinics 
over a 4.5 year period (see Figure 3 and Time Table in C.9). To optimize power while 
also ensuring an adequate number of participants within each clinic for each time period, 
steps will consist of 6-month periods. The number of clinics receiving PN will accumulate 
over time as shown in Figure 3. Based on this design, using a two-sided test and a 5% 
significance level, we will have greater than 90% power to detect a difference between 
PN and standard of care conditions, assuming a clinically meaningful effect of PN in 
reducing non-adherence rates from 25.9% to the CDC benchmark of 10%. This power 
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calculation accounts for any clustering within clinics (i.e., statistical correlation among 
the binary non-adherence outcomes from participants within the same cluster, as 
measured by the coefficient of variation). With an extremely conservative estimate of 10 
referred infants per clinic each period, and conducting a power calculation for the usual 
range of coefficients of variation from 0.15 to 0.4,90 statistical power ranged from 0.91 to 
0.96. Furthermore, with slightly larger cluster sizes of 15 referred infants per clinic each 
period, power was at least 0.98 under all scenarios. With 500-600 newborns with failed 
hearing screens referred to these clinics each year (see Figure 2 in C.4), we expect 
actual power to be higher. 
 
Aim 1 Potential Limitations and Alternatives 
Recruitment: The volume of referrals for infant hearing may fluctuate and the timing of 
such referrals may vary, which may impact recruitment. We will monitor this closely and 
work with CCSHCN clinics’ scheduling staff to efficiently and effectively enroll all eligible 
participants. Loss to Follow-up: Those who are non-adherent and lost to follow-up may 
have been tested at another institution. Our intent-to-treat analyses will maintain those 
participants in the study and we will assess their adherence using the EHDI database 
and individual follow-up attempts for data collection purposes. Control Group: Due to 
the study design, prior to rollout of PN, each clinic will be in a control condition and no 
individual-level data will be collected. If further individual-level data is needed from the 
control condition, we will consider recruiting participants from some of the clinics during 
standard of care. Turnover of PNs: Each clinic will be assigned 3 PNs. These 
navigators are not employed full-time in this study, thus, having a pool of navigators will 
allow for flexibility in delivery of the navigation intervention based on the availability of 
the navigator. Reimbursement of the navigators will be based on the number of 
participants navigated during the study. In the case of turnover, we will seek to 
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continually identify new candidates to serve as PNs within each clinic. If we are unable 
to recruit or maintain a PN in a particular clinic then we will utilize the centralized PNs for 
that clinic, regardless of randomized condition. We will pay the PNs per dyad navigated 
to improve retention of PNs. Alternate Study Designs: Each design considered for this 
project has limitations. For example, an RCT with individual randomization would add 
significant complexity, increase the likelihood of contamination, and require additional 
personnel and resources to identify and train PNs simultaneously in all ten clinics; a 
traditional cluster-randomized trial would have many of the same practical and 
complexity concerns. A typical crossover design would pose logistical and ethical 
challenges because (1) PN would be rolled out to 5 clinics at the same time, and (2) 
reverting to the control condition may be unacceptable. The stepped wedge design lends 
itself well to the goals of hybrid effectiveness-implementation studies and allows 
adequate time at multiple geographically dispersed clinics to identify and train PNs. 
Finally, this design is ideal because all clinics eventually cross to the PN condition, 
consistent with the preferences of our CCSHCN partners.  
Specific Aim 2 will investigate factors associated with implementation and effectiveness 
outcomes across the 10 clinic sites. This aim is guided by the Consolidated Framework 
for Implementation Research (CFIR),79 using implementation constructs and outcomes 
recommended by Proctor et al.91 Sources of data for this aim will include process 
records of PNs, clinic administrators, staff, and providers, and parent participants. The 
rationale for the procedures and measures proposed in this aim is illustrated in FIGURE 
3.3. To prepare for potential scale-up of PN, we must understand the 
implementation-related factors and outcomes that will maximize its public health 
impact. Consistent with CFIR, we will assess PN skill (knowledge and behaviors)  
3.4.6. Aim 2 Methods: Explore associations among implementation factors, 
implementation outcomes, and effectiveness outcomes. 
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FIGURE 3.3: Implementation Logic Model 
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following completion of the PN curriculum, including intervention fidelity; PN 
characteristics (including local vs. centralized); inner and outer setting clinic 
characteristics; and four key implementation outcomes: adoption, recruitment/retention, 
reach/penetration, and sustainability. 
 
Aim 2 Study Sample & Recruitment  
Patient Navigators: The PNs (N = 23: 3 PNs serving 5 clinics in the centralized PN 
condition; 15 serving 5 clinics in the local PN condition; 5 back-ups) will be enrolled as 
study participants as well to collect implementation data. PNs will be identified from an 
existing pool of parents/patients who have requested to be involved in hearing 
healthcare research and patient advocacy, maintained by the CCSHCN. During the 
selection process, potential PNs will be informed by trained research staff of the purpose 
of the study and will provide written informed consent to participate in study procedures. 
Inclusion criteria include: 1) age 21 years or older, 2) able to speak and read English, 
and 3) willing to complete the PN training curriculum and deliver PN. Local PNs will be 
required to reside within 50 miles of their CCSHCN clinic; the centralized PN will be 
required to reside within 50 miles of the University of Kentucky campus. At least one PN 
per clinic must be bilingual (Spanish-English). 
Clinic Administrators, Staff, and Providers: At each clinic, one administrator, one 
staff member, and one hearing healthcare provider (N=30) will be invited to participate in 
Aim 2. Inclusion criteria include: 1) age 18 years or older, 2) able to speak/read English. 
Parent Participants: All parent participants recruited in Aim 1 (N=1120) will also provide 
Aim 2 data during their baseline and post-test assessments. A subset of approximately 
20 (dependent on saturation) parent participants will be recruited through purposive 
sampling and invited to also complete qualitative key informant interviews during their 
post-test assessment, after providing written informed consent. These parents will 
 
 69 
represent a combination of urban vs. rural communities, non-adherent vs. adherent 
results, and receiving centralized vs. local PN. 
 
Aim 2 Procedures 
Patient Navigators: It is necessary to collect data regarding PN skill (knowledge and 
behaviors) to assess factors that influence successful implementation. There 2 types of 
navigators that are used during this study: 1) local navigators that live in close proximity 
to the clinic where they are assisting patients, and 2) central navigators that are located 
at the primary institution of the PI. The data to be collected will include measures of the 
PN knowledge regarding infant hearing loss diagnosis and treatment recommendations, 
PN behaviors in the intervention delivery, and PN characteristics (sociodemographic, 
local versus central navigator, attitudes toward evidence-based interventions). Baseline 
data collection from PNs will occur immediately following study enrollment and before 
PN training, comprising both quantitative and qualitative measures administered by a 
trained interviewer. At the conclusion of PN training, PNs will take an examination to 
ensure comprehension of critical principles necessary for successful navigation. A score 
>80% will be required to pass the training. PNs with less than a passing score will be 
allowed to repeat relevant training elements and retake the examination one time; if the 
examination is not passed on the second round, the PN will not be employed in this 
study and a new PN will be identified. PN skill is a key implementation factor, thus, for 
those who pass the examination and proceed to intervention delivery, this outcomes will 
be assessed by measuring the following: PNs will (1) audio-record 10% of PN sessions 
(with parent permission) to allow assessment of fidelity, (2) complete a PN fidelity 
checklist59 following each PN session, and (3) maintain process logs detailing time, 
travel, attendance, frequency and modes of contact with families, and other activities 
and expenses associated with PN delivery. Approximately 6 months after completing PN 
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training, PNs will be interviewed and complete post-test assessments, again 
administered by a trained interviewer. PNs will be compensated $25 at baseline and 
post-test for completing the battery of assessments. In each clinic, the PN intervention 
will continue after the 6-month assessment time point until the end of the 2nd quarter of 
year 5.  
Clinic Administrators, Staff, and Providers: Approximately 6 months after crossing to 
the PN condition, administrators, staff, and providers from each clinic will participate in 
qualitative interviews and complete quantitative measures administered by a trained 
interviewer. For key informant interviews, we develop and utilize a semi-structured open 
question interview script using a CFIR interview guide tool, 
(http://www.cfirguide.org/guide/app/index.html#/)92 for inner and outer settings for the 
Commission clinics. These constructs will include patient needs and resources, 
cosmopolitanism, peer pressure, external policy and incentives, structural 
characteristics, networks and communications, culture, implementation climate, 
compatibility, relative priority, organizational incentives and rewards, goals and 
feedback, learning climate, readiness for implementation, leadership engagement, 
available resources, access to knowledge and information 
(http://cfirguide.org/constructs.html).93  Research staff will contact all study candidates 
and informed consent will be obtained. A trained interviewer will conduct these 
interviews in-person with participants. Initial questions will be open-ended, and follow-up 
probes will be used to prompt clarification and elaboration of answers. Interviewers also 
will take field notes during and after each interview. These notes will focus on the tenor 
of the discussion and the participants’ non-verbal presentation. These participants will be 
compensated $25. 
Parent Participants: At the Aim 1 post-test assessment (16 weeks post-birth), parents 
will complete a PN satisfaction measure.75 Parents completing post-test measures will 
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be compensated $20 under Aim 1. : At the Aim 1 post-test assessment (16 weeks post-
birth), parents will complete a PN satisfaction measure.75 Selected parents (N = 
approximately 20) will also complete a 1-hour semi-structured key informant interview 
with a trained interviewer exploring parents’ experiences with the PN intervention. We 
develop and utilize a semi-structured open question interview script using a CFIR 
interview guide tool92 for characteristics of individuals. Related to patient navigation, 
these constructs will include knowledge and beliefs about the intervention, self-efficacy, 
individual stages of change, individual identification with organization, and other 
personal attributes.93 Research staff will contact all study candidates and informed 
consent will be obtained. A trained interviewer will conduct these interviews in-person 
with participants. Initial questions will be open-ended, and follow-up probes will be used 
to prompt clarification and elaboration of answers. Interviewers also will take field notes 
during and after each interview. These notes will focus on the tenor of the discussion 
and the participants’ non-verbal presentation. Parents completing post-test measures 
will be compensated $20 under Aim 1, and parents also completing key informant 
interviews will be compensated an additional $25. 
 
Aim 2 Measures 
All instruments and interviews will be administered in person by trained 
interviewers. Implementation outcomes of interest for this study include adoption, 
recruitment/retention, reach/penetration, and sustainability, as depicted in Figure 3.3. 
Adoption per clinic will be measured using a binary indicator of whether the PN 
intervention was delivered even once at each CCSHCN clinic; this variable will be 
measured using PN process records. Recruitment/retention per clinic will be measured 
using data from EHDI and PN process records: the number of parent-infant dyads 
contacted, screened for eligibility, and enrolled will be tracked, as well as numbers of 
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dyads lost to follow-up, with reasons recorded when known. Number of PN contacts with 
each dyad will also be recorded. Reach/penetration per clinic will be measured with the 
ratio of parent-infant dyads receiving any dose of the PN intervention to the number of all 
potential parent-child dyads referred; the numerator will be obtained from PN process 
records, while the denominator will be obtained from EHDI records. Sustainability per 
clinic will be measured by assessing PN activity each month and recording how many 
consecutive months (out of all months in which referrals for infant diagnostic testing 
occurred following the 6-month assessment time point) the PN intervention is delivered.  
Measures of CFIR implementation factors will include PN characteristics: 
knowledge (post-training examination score); fidelity (fidelity checklist and research staff-
rated transcripts of PN audiotapes); sociodemographic characteristics (age, sex, 
education, and previous related professional experience); attitude toward evidence-
based interventions (Evidence-Based Practice Attitude Scale-50 (EBPAS-50)94); self-
efficacy to deliver the PN intervention (Counselor Activity Self-Efficacy Scale 
(CASES)95); and PN modality (centralized versus local). Other factors include inner 
setting characteristics: number of full time employees employed at the clinic; clinic 
patient population size; clinic staff/adminstrator/provider-completed measures of 
communication, organizational culture, capacity, environmental supports and resources 
(Organizational Readiness to Change Assessment (ORCA)96 and Program Sustainability 
Assessment Tool (PSAT)97); and inner setting themes identified in key informant 
interviews of clinic staff/administrators/providers. Finally, measures of outer setting 
characteristics include: county population size; designation as Appalachian versus non-
Appalachian county; rural versus urban; and number of competing service providers in 
the county. All outer setting characteristics will be collected from existing data sources 
(e.g., state and Census data, provider referral lists from referring hospitals). Outer 
setting themes will also be identified in key informant interviews of clinic 
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staff/administrators/providers. Parent satisfaction with the PN intervention will also be 
measured as an implementation factor, using the Patient Navigation Satisfaction 
Inventory75 administered at the post-test assessment. Measures for Aim 2 are based on 
up-to-date reviews of available instrument repositories (Seattle Implementation 
Research Collaborative (SIRC) and Grid-Enabled Measures-Dissemination & 
Implementation (GEM-D&I)); however, measurement of implementation constructs is a 
rapidly evolving field, and consensus on recommended quantitative measures for many 
of these constructs is still in development.91,98 Characteristics of individuals are also key 
implementation factors and these constructs will be assessed from parent interviews 
regarding patient navigation. 
 
Aim 2 Analyses 
Because this is a type 2 hybrid effectiveness-implementation trial, most Aim 2 
analyses are exploratory in nature and intended to inform potential scale-up and multi-
state evaluation of implementation of PN (if found to be effective in this trial). Aim 2 
employs a convergent mixed-methods approach to interpret quantitative and qualitative 
findings simultaneously.99 For all quantitative measures, we will obtain descriptive 
statistics and conduct exploratory comparisons among the 10 clinics, with particular 
attention to PN, inner, and outer setting characteristics that seem to be associated with 
effectiveness and implementation outcomes. As in Aim 1, exploratory analyses of the 
quantitative data described in C.6.c above will use marginal (population average 
interpretation) generalized linear models (i.e., a linear model will be utilized for a 
continuous outcome and a logistic model for a binary outcome). Analyses comparing 
patient-level data between clinics will utilize the same general GEE approach described 
in Aim 1 to account for clustering of outcomes in the same clinic.  
Additionally, we will examine the effects of the implementation factor of PN 
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modality (centralized versus local) on clinic-level non-adherence rates. We will use the 
same modeling strategy described for the primary effectiveness outcome in Aim 1 (see 
C.5.c), but the fixed effects for trial condition will be extended to account for three 
conditions (standard of care, centralized PN, local PN) in this exploratory analysis. 
For key informant interviews, CFIR constructs of interest, as described above, 
will be used to categorize themes generated by the key informants regarding individual 
characteristics of parents, inner clinic setting, and outer clinic setting factors affecting 
implementation of the PN intervention in CCSHCN clinics across Kentucky. Digital 
recordings of key informant interviews will be transcribed in full. Transcripts will be 
compared to interview notes by the interviewer the PI. Facilitated by use of Atlas.ti,100 
transcripts will be coded line-by-line. The qualitative research team will co-code the text, 
develop an initial codebook for each CFIR theme (i.e., individual characteristics, inner 
setting, and outer setting), and use concordant and discordant codes to refine and 
develop final codebook versions. After both raters re-code the first transcripts, the results 
will be analyzed for inter-rater reliability. If reliability does not reach or exceed 0.85, the 
raters will re-examine concordant and discordant coding and revise codes and 
definitions accordingly until consensus is achieved.101 
After achieving adequate inter-rater reliability, the coding process will continue for 
the rest of the transcriptions. Four randomly selected transcripts will be identified for 
double-coding and evaluation of inter-rater reliability, followed by any needed 
modifications and recoding to achieve adequate inter-rater reliability. Once initial topical 
coding has been completed, 10% of the sample (i.e., 2 parents and 3 clinic 
staff/administrators/ providers) will be invited to participate in a member-checking 
process to determine whether additional data collection is necessary and to ensure valid 
inferences are made through coding procedures.102 Participants involved in member-
checking will receive an additional $25 compensation for their time and effort. Following 
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the member-checking process and any needed corrections to the codebooks and 
coding, the investigative team will meet to review the results of the topical coding 
process and develop a summative grid of themes emerging from the interviews.  
The summative grid of themes will be considered with the quantitative results 
describing implementation factors and outcomes in a series of investigator meetings 
designed to integrate these findings. Interpretations will be discussed with all co-
investigators, and differences will be resolved through discussion and revisiting of 
primary data. As recommended by Creswell and colleagues,99 the convergent mixed-
methods design of Aim 2 will allow us to simultaneously consider quantitative and 
qualitative data from multiple perspectives to contextualize and gain a more complete 
understanding of key implementation factors linked with the effectiveness and 
implementation outcomes of PN.  
 
Aim 2 Power and Sample Size Calculations 
Because Aim 2 is primarily exploratory, the sample sizes for this study are based 
on power calculations for the primary effectiveness outcome in Aim 1. With only 10 
clinics participating, we may not have adequate power to detect significant associations 
among implementation factors and outcomes (e.g., adoption, sustainability). However, 
we will have sufficient power to detect differences in the primary effectiveness outcome 
(clinic-level non-adherence rate) by local vs. centralized PN compared to the standard of 
care condition. Specifically, using a two-sided test, a 5% significance level, and assumed 
non-adherence of 10% in either PN condition and 25.9% in standard of care, our 
conservative power calculations suggest that with 5 clinics per PN condition we will have 
statistical power ranging from 0.80 to 0.87 to compare local PN to control and 
centralized PN to control. This particular implementation factor is modifiable and results 
will inform both scale-up and future implementation studies. For our qualitative analyses, 
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the numbers of parents, clinic staff, administrators, and providers planned for key 
informant interviews are based on previous work and expectations regarding the number 
of participants needed to attain saturation.103 
  
Aim 2 Potential Limitations and Alternatives 
As described under Aim 1, potential Aim 2 limitations include difficulties with 
recruitment, loss to follow-up, and turnover of PNs. Our strategies to overcome these 
roadblocks are the same as described under Aim 1. In Aim 2, however, each of these 
roadblocks also relates directly to the implementation factors and outcomes under 
investigation; thus, encountering these problems and exploring their causes (e.g., low 
self-efficacy of PNs leading to turnover; low satisfaction of parents with PN leading to 
drop-out) will actually inform our Aim 2 analyses and conclusions and allow us to identify 
strategies to improve implementation of PN.  
 
Specific Aim 3 involves incremental cost-effectiveness analyses in which net 
costs and net effectiveness of the intervention will be compared with that of standard of 
care for patients referred to CCSHCN clinics after a failed newborn hearing screen. 
Hypotheses: (a) PN of either kind after a failed newborn hearing screen will be cost 
effective compared to the standard of care from the perspective of third-party payers; (b) 
Centralized PN will be as or more cost-effective than local PN.  We will compare net 
costs and effectiveness of each PN modality–centralized versus local–compared to 
standard of care. Results will be expressed as a ratio of differences in observed costs to 
differences observed outcomes. The perspective of this evaluation will be third party 
payers.  
3.4.7. Aim 3 Methods: Determine cost-effectiveness of PN from the perspective 
of third party payers 
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Aim 3 Measures 
Costs: Both direct and indirect costs associated with PN will be included. Costs 
associated with the initial newborn hearing screen will be excluded from analyses since 
these costs are incurred for all infants regardless of outcomes. Direct costs include the 
cost of: PN establishment (PN recruitment and training costs), program implementation 
(office space, PN time, PN travel and tools, PN materials, staff turnover), parent time 
and travel (travel to seek diagnostic or PN services, time spent receiving diagnostic 
services), treatment costs (costs of a rescreen or diagnostic audiology appointment), 
and non-adherence costs for the clinics (no-show appointments). Research activity costs 
(e.g., data collection, human subject protection training of PNs) are not included. 
Indirect costs include opportunity costs of time (e.g. loss of productivity/wages) for the 
parent(s). Cost data will be collected and monitored annually throughout the study 
period, for both the intervention and standard of care conditions. Unit program costs will 
be documented as Aims 1 and 2 are implemented and sustained over the study period. 
Unit costs of PN and parent participant travel will be estimated using the distance 
between patient and clinic address/zip code multiplied by the standard GSA standard 
mileage rate and adding any lodging expenses (if applicable). Unit costs of PN time will 
be estimated using logs maintained by the PNs and applying the hourly PN pay rate. 
Parent participant time will be estimated using the average wage rate for Kentucky 
(estimated using average wage data from the Bureau of Labor Statistics (BLS)). Unit 
treatment costs will be estimated using charge data from the CCSHCN, aggregated at 
the clinic level. Unit costs of non-adherence will be based on costs of PN time not used 
but spent (which may vary if services are centralized versus local) and staff costs 
associated with rescheduling. Loss of productivity will be estimated using an estimate of 
time away from work (calculated using driving distance) and lost wages for one parent, 
using BLS average wage statistics.  
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Effectiveness: The measured outcome of effectiveness to which costs will be 
compared is the proportion of individuals in each group who achieve diagnosis by 3 
months of age. We will derive these outcome data using clinic-level non-adherence rates 
reported monthly by EHDI, collected in Aim 1.  
 
Aim 3 Analyses  
The cost-effectiveness analysis will follow analytic procedures outlined by Muennig and 
Bounthavong.104 We will estimate costs associated with an incremental change 
(measured as an increase or decrease in percentage points) in effectiveness for each 
PN modality compared to standard of care (prior to a clinic crossing to the PN condition). 
FIGURE 3.4 illustrates the anticipated flow of events in the PN. Using effectiveness and 
implementation data from Aims 1 and 2, we will apply probabilities and costs to each 
terminal event outlined to model estimated cost-effectiveness for each outcome. The 
analyses will be performed using TreeAge Pro software.105 Results will be reported as a 
ratio of incremental cost to incremental effectiveness for each terminal event, comparing 
costs and outcomes of each PN group to the standard of care group, and, separately. An 
incremental cost effectiveness ratio (ICER) will be calculated for each alternative to 
determine the relative difference in costs associated with a percentage change in 
effectiveness for each alternative. The general ICER equation is: ICER = (𝐶𝐶1−𝐶𝐶0)
(𝐸𝐸1−𝐸𝐸0)
, where: 
C1 = Costs associated with PN, PN centralized, PN local; C0 = Costs associated with 
standard of care; E1 = Effectiveness (outcomes) associated with PN, PN centralized, PN 
local; and E0 = Effectiveness (outcomes) associated with standard of care.  For any 
alternative with positive incremental cost but negative incremental effectiveness, an 
ICER is not meaningful and thus will not be calculated. 
The calculated ICERs can be used to determine which alternative may produce 
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FIGURE 3.4. Flowchart of Possible Events 
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the best outcome without exceeding stakeholders’ threshold of willingness-to-pay. As 
this threshold is generally unknown, results will be presented for alternative thresholds 
and reported using cost-effectiveness acceptability curves to plot the probability of each 
alternative being cost-effective in relation to different values of willingness-to-pay, 
presented in dollars.106 In addition, we will use one-way sensitivity analyses to account 
for uncertainty in our parameter estimates, including the number of participating families, 
costs of implementation, and PN effectiveness. For each key parameter, the sensitivity 
analysis will estimate the expected value of PN given changes in each parameter, using 
the estimate derived from study data plus or minus 20 percent. The results of the 
analysis will be prepared as technical documents for presentation to the Kentucky 
Medicaid program and other third-party payers that make policy decisions regarding 
covered services. The results of the sensitivity analyses will further assist payers in 
determining interest and ability to reimburse for PN services. 
 
Aim 3 Potential Limitations and Alternatives 
If aim 1 does not demonstrate effectiveness of patient navigation to reduce non-
adherence, then this could serve as a challenge for this cost-effectivenss aim. Even if 
the intervention is not effective in the primary outcomes, this aim will still provide 
valuable information because, according to a national taskforce for EHDI programs, all 
states must develop and implement family support interventions.10 An assessment of 
cost-effectiveness of PN will be useful to further develop more effective interventions. If 
PN under either modality does not demonstrate cost-effectiveness, the study results 
remain useful in terms of identifying target areas for potential cost reduction and as 
guidance for others considering implementation of similar PN programs. Another 
potential challenge in Aim 3 is accurate measurement of costs. The study requires 
reliable data on PN implementation and treatment costs, and necessitates detailed 
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monitoring throughout the study period. Despite the challenge of collecting these data, 
all stakeholders in this PN program have committed to providing the cost data outlined.  
 
3.5. RIGOR AND REPRODUCIBILITY 
As described in the Significance section, no interventions have been shown to 
reduce non-adherence to diagnostic testing in this population. Our preliminary data, 
based on a well-designed RCT, suggests that the PN intervention could be very effective 
in reducing non-adherence, but a larger effectiveness study is needed. Our selection of 
the pragmatic stepped wedge design maximizes feasibility and will achieve robust and 
unbiased results. The biological variable of sex of parents and infants is included in Aim  
1 effectiveness analyses; sex of PNs will be assessed in Aim 2 assessment of PN 
characteristics as implementation factors. To address reproducibility and transparency, 
we will also publish our study protocol and provide detailed methods and results. We will 
also share study data and systematically disseminate our results to stakeholders, 
researchers, and practitioners, as described in the Resource Sharing Plan section. 
 
3.6. IMPLICATIONS AND FUTURE DIRECTIONS 
 We seek to follow the time timeline outlined in FIGURE 3.5. This study is critical 
to assess the effectiveness, implementation factors, and cost of PN to improve delivery 
of infant hearing healthcare within a larger state-funded clinic environment. These data 
will be used to inform health policy on state and national levels. If PN is found to be 
effective in these settings, future research will investigate the implementation of PN into 
multiple practice types (university-based, private, state-funded) in a multi-state trial. 
Other directions include testing effects of PN on adherence to hearing healthcare 
treatment. This research is the first of its kind in hearing healthcare, will be rapidly 
translatable to practice, and will contribute to implementation science.  
 
 82 
FIGURE 3.5. Study Time Table 
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APPENDIX 1 
Newborn Hearing Parent Questionnaire (Entrance) 
Please read each of the below questions and mark the box or boxes next to your 
response. Your name and your child’s name will not be attached to any of your 
responses. We ask the same parent to fill out this questionnaire each time. 
Study ID:____________________________________ 
Date:______________________________________ 
Contact phone:______________________________ 
Consent Form signed         Date: _______________     
 
1. Which county do you live in? _______________________________ 
 
2. How long does it take you to drive to the University of Kentucky? 
      ______________hour(s)     ____________minutes 
 
3. What is your gender?  
   Male   Female 
4. How are you related to this child? (Please check one.) 
  Mother 
   Father 
   Relative 
   Friend 
   Other (Please explain: ______________________________________) 
5. What is your ethnicity?  
 White/Caucasian 
 Black/African American 
 Hispanic /Latino  
 Asian /Pacific Islander    
 Native American/American Indian 
 Other 
 
6. When is your birthday? ________ (mm/dd/yyyy) 
 
7. What is your marital status? 
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  Single, never married 
   Married/domestic partnership  
  Widowed 
   Divorced/Separated  
 
8. How many children do you have?   _____________ 
 
9. How many years of education have you completed? 
 Less than Middle School 
 Some High School 
 Completed High School/GED 
 Some college 
 College   
 Graduate Degree 
 
10. What is your annual household income? 
 >$10,000 
 $10,000-20,000 
 $20,000-30,000 
 $30,000-60,000 
 >$60,000 
 
11. What is your current employment status? 
 Employed for wages 
 Self-employed 
 Out of work and looking for work 
 Out of work but not currently looking for work 
 A homemaker 
 A student 
 Military 
 Retired 
 Unable to work/Disabled 
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12.  Yes No 
Did you smoke or use tobacco while 
pregnant?   
Did you use alcohol while pregnant?   
Did you use any illicit drugs or 
prescription drugs not prescribed to you 
while pregnant? 
  
 
 
The following questions are about your child who did not pass the hearing screening  
test given right after birth at the hospital. 
 
13. What kind of health insurance does your child have? (Please check as many as 
apply.) 
   Medicaid 
   K-Chip 
   Private or HMO/PPO 
   None 
   Other (Please explain: ______________________________________) 
14.  
Yes No 
Does your child have an established 
primary doctor (Doctor, Nurse Practitioner, 
or Physician Assistant)? 
  
Did someone in the hospital tell you that 
your baby had a newborn hearing 
screening test? 
  
Were you told the results of your child’s 
newborn hearing screening test?   
Do you understand why your child had a 
newborn hearing screening test?   
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15. When were you told the results of the hearing screening test?  
   Right after the screening test was finished 
  Some time after the screening test was conducted, but before leaving the 
hospital 
   I was not told the results 
  Other (Please explain: __________________________________) 
 
16. What were you told when you were given the results of the newborn hearing 
screening test? 
(Please write your answer below): 
 
 
 
 
 
 
 
 
 
17. Your child was recommended to have follow-up testing on the: 
   Right ear 
   Left ear 
   Both ears 
   I do not know 
 
18. How important do you think it is to follow up for more testing of your child’s 
hearing? (Please check one.) 
          
        Not at all              A little              Pretty         Extremely 
       Important                       important           important       important 
 
19. Do you have anyone in your family with hearing loss? 
  Yes    No    I do not know 
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Tell us which family members have hearing loss (Father, mother, brothers, 
sisters…) 
____________________________________________________________ 
 
20. Please read the following items and check the box for each one that shows 
how much you agree or disagree with that statement. 
 Strongly 
Disagree Disagree Undecided Agree 
Strongly 
Agree 
My child’s health 
insurance will make it 
hard to follow-up for 
hearing testing. 
     
The distance to the 
clinic will make it hard to 
follow-up for my child’s 
hearing testing. 
     
Difficulty getting 
appointments will make 
it hard to follow-up for 
my child’s hearing 
testing. 
     
My home 
responsibilities will 
make it hard to follow-up 
for my child’s hearing 
testing. 
     
My job responsibilities 
will make it hard to 
follow-up for my child’s 
hearing testing. 
     
Please write down any 
other things that might 
make it difficult to 
follow-up for your 
child’s hearing testing in 
the space below: 
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21.  Yes No 
I do not 
know 
Do you believe that newborn hearing screening 
is important?    
Do you believe that the newborn hearing 
screening results are accurate?    
Would you like help in attending follow-up 
appointments for your child’s hearing from UK 
Healthcare? 
 
   
 
22. Please describe in what ways UK Healthcare could make this hearing testing 
process easier for you.  (Please answer in the space below): 
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23. Please read the following items and check the box for each one that shows 
how much you agree or disagree with that statement. 
 Strongly 
disagree Disagree Undecided Agree 
Strongly 
Agree 
I would like to talk with 
my child’s primary 
doctor about the hearing 
test results. 
     
I feel that there are 
doctors in my area who 
can test my child’s 
hearing 
     
I feel my family will 
accept and support my 
child, regardless of the 
hearing tests results. 
     
I feel uncomfortable 
talking about my child’s 
hearing to others. 
     
I feel confident about 
the steps that need to be 
taken to check my 
child’s hearing 
     
I’m afraid about what the 
future hearing testing 
may show about my 
child 
     
I do not know what to 
expect with regard to 
future hearing testing 
     
 
24. The latest a child born with hearing loss should be diagnosed with hearing 
loss is:  
 3 months after birth  
 6 months after birth 
 9 months after birth 
 12 months after birth 
 
25. A child born with hearing loss should have started treatment no later than:  
 3 months after birth  
 6 months after birth 
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 9 months after birth 
 12 months after birth 
 
26. Please read the following items and check the box for each one that shows 
how much you agree or disagree with that statement. 
 Strongly 
Disagree Disagree Undecided Agree 
Strongly 
Agree 
I am knowledgeable 
about the testing 
process for newborn 
hearing health.  
     
Finding out my child’s 
hearing test result was 
upsetting. (Leave blank 
if you did not receive 
the results) 
     
Hearing is important for 
a child’s social 
relationships. 
     
Hearing is important for 
a child’s school 
performance. 
     
Early intervention 
services can help 
families with children 
who have hearing loss. 
     
There is no health 
treatment for newborn 
hearing impairment. 
     
 
Thank you for the time you have spent answering these questions. If there is 
anything else that you would like to share with us— comments, complaints, 
compliments, concerns, or questions— please use this page to do so.  
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APPENDIX 2 
 
Newborn Hearing Parent Questionnaire (Exit Interview) 
Please read each of the below questions and mark the box or boxes next to your 
response. Your name and your child’s name will not be attached to any of your 
responses. We ask the same parent to fill out this questionnaire each time. 
Study ID:______________________________ 
Date:_________________________________ 
Contact phone:______________________________ 
 
1. Which county do you live in? _______________________________ 
 
2. What is your sex?  
 
   Male   Female 
 
3. When is your birthday? ________ (mm/dd/yyyy) 
 
4. What is your current employment status? 
 Employed for wages 
 Self-employed 
 Out of work and looking for work 
 Out of work but not currently looking for work 
 A homemaker 
 A student 
 Military 
 Retired 
 Unable to work/Disabled 
 
5. How long does it take you to drive to the University of Kentucky? 
______________hour(s)    _________________minutes 
 
6. How do you normally travel to doctor appointments? 
 Personal vehicle 
 Family/Friends bring me 
 Public transportation 
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The following questions are about your child who did not pass the hearing screening 
given right after birth at the hospital. 
 
7. What kind of health insurance does your child have? (Please check as many as 
apply.) 
   Medicaid 
   K-Chip 
   Private or HMO/PPO 
   None 
   Other (Please explain: ______________________________________) 
 
8. How are you related to this child? (Please check one.) 
  Mother 
   Father 
   Relative 
   Friend 
   Other (Please explain: ______________________________________) 
 
9. Did you understand why your child had a hearing screening in the newborn 
nursery? 
   Yes    No 
 
10. Did someone in the hospital tell you about your appointment today? 
  Yes    No 
 
11. Do you understand why you child has a hearing test today? 
  Yes    No 
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12. What were you told regarding the reasons for this appointment? (Please write 
your answer below): 
 
 
13. Not at all 
Important 
A little 
Important 
           
Pretty 
Important 
Extremely 
Important 
How important was the hearing 
screening test that your child 
received in the newborn 
nursery? 
 
    
How important do you feel it 
was to follow up today for 
testing of your child’s hearing? 
    
 
14. Do you have anyone in your family with hearing loss? 
  Yes 
   No 
   I do not know 
Tell us which family members have hearing loss (Father, mother, brothers, 
sisters…) ______________________________________________________ 
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15. Please read the following items and check the box for each one that shows 
how much you agree or disagree with that statement. 
 Strongly 
Agree Agree Undecided Disagree 
Strongly 
Disagree 
My child’s health insurance 
made it hard to follow-up for 
hearing. 
     
The distance to the clinic 
made it hard to follow-up for 
my child’s hearing. 
     
Difficulty getting 
appointments made it hard 
to follow-up for my child’s 
hearing. 
     
My home responsibilities 
made it hard to follow-up for 
my child’s hearing. 
     
My job responsibilities will 
make it hard to follow-up for 
my child’s hearing. 
     
 
 
Please write down any other things that made it difficult to follow-up 
for your child’s hearing in the space below: 
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16. Please read the following items and check the box for each one that shows 
how much you agree or disagree with that statement. 
 Strongly 
Disagree Disagree Undecided Agree 
Strongly 
Agree 
I have talked with my 
child’s primary doctor 
about the hearing 
screening done in the 
newborn nursery. 
     
My child’s primary doctor 
recommend follow-up 
testing of my child’s 
hearing. 
     
I feel that there are 
doctors in my area who 
can test for and treat 
hearing loss  
     
I feel my family has been 
supportive in the getting 
my child’s hearing tested 
     
I have talked with friends 
and family about the 
hearing screening done in 
the newborn nursery. 
     
I feel confident about the 
steps that need to be 
taken to check my child’s 
hearing 
     
I feel uncomfortable 
talking about my child’s 
hearing testing to others. 
     
 
17. Please tell us how difficult it would be to obtain the following services:  
 Extremely 
difficult 
Slightly 
difficult Not difficult 
Readily 
accessible 
I don’t 
Know 
Audiologist (someone 
who checks hearing)       
Speech therapist       
Primary doctor 
(Doctor, Nurse 
Practitioner, or 
Physician Assistant) 
      
Ear, Nose, and 
Throat doctor       
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18. The latest a child born with hearing loss should be diagnosed with hearing 
loss is:  
 3 months after birth  
 6 months after birth 
 9 months after birth 
 12 months after birth 
 
19. A child born with hearing loss should have started treatment no later than:  
 3 months after birth  
 6 months after birth 
 9 months after birth 
 12 months after birth 
 
20. Please read the following items and check the box for each one that shows 
how much you agree or disagree with that statement. 
 Strongly 
Disagree Disagree Undecided Agree 
Strongly 
Agree 
Hearing is important for a 
child’s social 
relationships. 
     
Hearing is important for a 
child’s school 
performance. 
     
Early intervention services 
can help families with 
children with hearing loss. 
     
 
 
21. Would you like more help to attend follow-up appointments for your child’s 
hearing? 
  Yes    No    Unsure 
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22. Please answer the following questions regarding your experience  
 Strongly 
Disagree Disagree Undecided Agree 
Strongly 
Agree 
I am more knowledgeable 
about the testing process 
for newborn hearing health 
since I left the hospital 
     
I understand how to 
proceed with my infant’s 
hearing care 
     
I have been provided 
adequate information and 
resources regarding 
newborn hearing loss 
     
I am an integral part of my 
child’s hearing healthcare 
team 
     
Finding out my child’s 
hearing test result was 
upsetting. 
     
The help I received from 
the UK Healthcare to get 
my child’s hearing tested 
was adequate 
 
     
I feel comfortable 
providing information to 
other parents about 
newborn hearing loss and 
the hearing testing 
 
     
I would be interested in 
helping other parents learn 
about hearing loss and the 
hearing screening 
process.  
 
     
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23. Please describe in what way UK Healthcare could have made this hearing 
process easier for you.  (Please answer in the space below): 
 
 
 
 
 
 
 
 
 
24. How difficult was the process of having your child’s hearing loss diagnosed? 
(Please check one.) 
          
        Not at all              A little              Pretty         Extremely 
         difficult                         difficult                        difficult                       difficult 
 
Thank you for the time you have spent answering these questions. 
If there is anything else that you would like to share with us— comments, 
complaints, compliments, concerns, or questions.  Please use the rest of this 
page to do so.  
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APPENDIX 3 
 
Patient Navigator Interview Guide: 
 
Phone Contact 1 (initially after discharge) 
Let the participant know that we do record the phone conversation for review to 
assess discussion and find better ways of helping families through navigation. 
 
Greetings and Building Trust – Remind participant of the study and the definition 
of a patient navigator and rapport building through asking about the participant 
and newborn. 
 
a.  Study purpose:  We would like to see if the support and educational tools from a 
patient navigator are helpful in reducing barriers to hearing health for your child.  You 
were randomized to the patient navigator, so you will have weekly to every other week 
phone calls until you come in for your child’s hearing test by an audiologist, or hearing 
professional. 
b.  Patient navigator:  A person who has interest in pediatric hearing health or has been 
trained to provide support and give resources to parents of children who fail the newborn 
hearing screening or who have hearing loss.  This person will provide guidance and 
follow up with you to answer any questions regarding your child’s condition. 
 
2.  Building rapport through asking about the participant and newborn 
 
a.   Tell me a little about yourself and your family. 
b.   How is your family adjusting to the newborn? 
c. What are you fears or concerns about your infant’s hearing? the follow-up hearing 
testing? 
 
3. Has the baby seen the pediatrician?  Did you speak to the doctor about the 
newborn hearing screening?  What were you told about the results? 
 
4.  Inquiry about the hearing test date and any questions related about 
expectations for the visit 
a.   Give the participant the test date/time and let her/him know that she/he will be 
contacted by the Audiology Department a day or two before the appointment.  If he/she 
has any additional questions related to the visit, she/he can contact Audiology directly or 
contact the navigator. 
b.  Does the participant have an understanding of what to expect at the ABR (Auditory 
Brainstem Response) test?   
      - Stickers that detect how well a baby is hearing are placed on the baby’s forehead 
and behind the ears 
      - We hope that the baby will sleep during the test.  If he or she does not sleep, you 
may have to return for a follow up visit to get an accurate test.  We do not perform 
sedated ABRs.  The baby can have a bottle or pacifier before the test, but once the test 
has begun, those items will cause noise on the test and cannot be used. 
      - During the test the baby stays asleep in a parent’s lap and testing is done for about 
20-30 minutes.  If the baby wakes up, there will be a few minutes to try to get the baby 
back to sleep.   
      - After the test, the audiologist will let you know the results of the test and whether or 
not your baby needs to return for additional testing.  Sometimes your baby may need to 
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grow further to get an accurate test, so he or she may have to come back for further 
testing. 
 
4.  Navigator reviews the standard of care recommendations:  1, 3, 6, 12 month 
steps 
a.  Newborn Hearing Screening completed by 1 month (already completed!) 
b.  Diagnosis by 3 months by an hearing test called an ABR (Auditory Brainstem 
Response) completed by an hearing professional called an audiologist.  Primary care 
doctors do not have the specialized equipment or the training to do this test in his or her 
office. 
c.   If a child is diagnosed with hearing loss, he or she will have to have another ABR by 
a different audiologist to determine a diagnosis.  There is available assistance, but a 
child should have hearing aids if needed or any beginning therapy starting before 6 
months old. 
d.   If a child needs a cochlear implant, this should be done at about 12 months old.   
 
5.  Are there any community or UK resources that relate to your child health care 
that we can provide to you at either follow up phone calls or give to you in person 
when we see you in the Audiology Clinic? 
 
 
 
Phone Contact 2 (follow up from first phone contact) at Week 2 or Week 3 
 
Participant reminded that phone conversation will be recorded to assess the 
discussion 
 
1.  Greetings and any questions that were discussed from the first phone call 
 
2.  Make sure the participant knows where to park and the clinic location 
 
3.  Review information from the last phone conversation and answer any 
questions the parent may have since that last phone call. 
 
4.  Has the baby seen the pediatrician?  Did you speak to the doctor about the 
newborn hearing screening?  What were you told about the results? 
 
4.  Inquiry about the hearing test date and any questions related about 
expectations for the visit 
a.   Give the participant the test date/time and let her/him know that she/he will be 
contacted by the Audiology Department a day or two before the appointment.  If he/she 
has any additional questions related to the visit, she/he can contact Audiology directly or 
contact the navigator. 
b.  Does the participant have an understanding of what to expect at the ABR (Auditory 
Brainstem Response) test?   
      - Stickers that detect how well a baby is hearing are placed on the baby’s forehead 
and behind the ears 
      - We hope that the baby will sleep during the test.  If he or she does not sleep, you 
may have to return for a follow up visit to get an accurate test.  We do not perform 
sedated ABRs.  The baby can have a bottle or pacifier before the test, but once the test 
has begun, those items will cause noise on the test and cannot be used. 
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      - During the test the baby stays asleep in a parent’s lap and testing is done for about 
20-30 minutes.  If the baby wakes up, there will be a few minutes to try to get the baby 
back to sleep.   
      - After the test, the audiologist will let you know the results of the test and whether or 
not your baby needs to return for additional testing.  Sometimes your baby may need to 
grow further to get an accurate test, so he or she may have to come back for further 
testing. 
 
5.  Give sleep deprivation instructions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 102 
APPENDIX 4 
 
Patient Navigator Satisfaction Questionnaire 
Please read each of the below questions and mark the box or boxes next to your 
response. Your name and your child’s name will not be attached to any of your 
responses. We ask the same parent to fill out this questionnaire each time. 
 
 
Strongly 
Disagree Disagree Undecided Agree 
Strongly 
Agree 
My navigator gives me 
enough time      
My navigator makes me feel 
comfortable      
My navigator is dependable      
My navigator is courteous 
and respectful to me      
My navigator listens to my 
problems      
My navigator is easy to talk 
to      
My navigator cares about me 
personally      
My navigator figures out the 
important issues in my 
healthcare 
     
My navigator is easy to 
contact      
 
 
 
 
Thank you for the time you have spent answering these questions. 
If there is anything else that you would like to share with us about your experience 
with the patient navigator, please use the back of this page to do so. Comments, 
complaints, compliments, concerns, or questions are welcome.  
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Center, Lexington, Kentucky. April 8, 2013. 
2013 Osetinsky M, Shinn J, Fardo, Gal TJ, Schoenberg N, Bush M. Congenital 
Sensorineural Hearing Loss in Appalachia. AOA Groves Memorial MD/PhD 
Program Student Research Symposium, University of Kentucky, Lexington, 
Kentucky. February 20, 2013. 
2012 Bush M, Bridging the Gaps: Assessment of Appalachian Pediatric Hearing Loss. 
Twentieth Annual Department of Otolaryngology Saunders Symposium. The 
Ohio State University, Columbus, OH. June 22, 2012. 
2012 Cipolla M, Iyer P, Dome C, Welling DB, Bush M. Paul Holinger, MD Resident 
Research Award (Middle Section). Modification and Comparison of Minimally 
Invasive Cochleostomy Techniques: A Pilot Study. The Triological Society 
Combined Sections Meeting, Miami, FL. January 26, 2012. 
2011 Bush M, AR42, A Novel Histone Deacetylase Inhibitor, as a Potential Therapy 
for Vestibular Schwannomas and Meningiomas. Nineteenth Annual Department 
of Otolaryngology Alumni Symposium. The Ohio State University, Columbus, 
OH. June 24, 2011. 
2011 Burns S, Akhmametyeva E, Oblinger J, Bush M, Huang J, Senner V, Giovannini 
M, Chen CS, Jacob A, Welling DB, Chang LS. AR-42 and AR-12 Potently Inhibit 
the Growth of NF2-deficient Human Meningiomas. Childrens Tumor Foundation 
NF Conference. Jackson Hole, WY. June 14, 2011. 
2011 Bush M, Oblinger J, Davletova S, Burns S, Chang LS, Welling DB, Jacob A. 
Treatment of Vestibular Schwannoma Cells with ErbB Inhibitors. Combined 
Otolaryngology Society Meeting (American Neurotology Society). Chicago, IL. 
April 30, 2011.  
2010 Oblinger J, Lee T, Packer M, Huang J, Bush M, Kulp S, Chen CS, Giovannini M, 
Welling DB, Jacob A, Chang LS. HDAC42 and OSU-03012, Novel Small-
Molecule Inhibitors for the Treatment of Vestibular Schwannomas. Children’s 
Tumor Foundation NF Conference. Baltimore, MD. June 8, 2010.  
2009 Bush M, Oblinger J, Kulp S, Chen CS, Jacob A, Chang LS, Welling DB. Novel 
Inhibitors of Vestibular Schwannomas and Meningiomas. American Acadcemy of 
Otolaryngology – Head and Neck Surgery Annual Meeting. San Diego, CA. 
October 6, 2009.  
2009 Oblinger J, Bush M, Kulp S, Chen CS, Jacob A, Chang LS, Welling DB. 
Radiosensitization of Vestibular Schwannomas by HDAC42. American 
Acadcemy of Otolaryngology – Head and Neck Surgery Annual Meeting. San 
Diego, CA. October 6, 2009. 
2008 Bush M, Jones R, Shinn J.  Test-Retest Reliability of VEMPS.  Kentucky Society 
of Otolaryngology Annual Meeting.  Harrodsburg, KY April 18, 2008. 
2008 Bush M, Shinn J, Young B, Jones R.   Long-term Hearing Results in Gamma 
Knife Radiosurgery for Acoustic Neuromas.  The Triological Society Southern 
Section Meeting, Naples, FL. January 10-12, 2008. 
2007 Bush M, Shinn J, Young B, Jones R.   Long-term Hearing Results in Gamma 
Knife Radiosurgery for Acoustic Neuromas.  Kentucky Society of Otolaryngology 
Annual Meeting, Louisville, KY.  May 18-19, 2007. 
2006 Bush M, Jones R, Musiek F & Shinn J. Auditory Brainstem Response and 
Behavioral Testing in Acoustic Neuroma Detection, Kentucky Society of 
Otolaryngology Annual Meeting, Dale Hollow Lake Resort, KY.   May 19-20, 
2006 
2006 Shinn J, Bush M. Current Trends in Electrophysiology. University of Connecticut 
1st Annual Symposium on (C)APD. Storrs, CT. 
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POSTER PRESENTATIONS 
 
2016 Ritchie R, Alfonso K, Cheriyan M, Bush M, Jones R, Weihing J, Shinn J. Effect 
of Noise on Anesthesiologist Auditory Processing in the Operating Room. 
International Anesthesia Research Society Annual Meeting and International 
Science Symposium. San Francisco, CA. May 21-24, 2016. 
2016 Chan S, Hixon B, Shinn J, Bush M. Hearing Loss in Rural Adults: A Geographic 
Comparison of Access to Care in Hearing Aid Recipients. American Otological 
Society Annual Meeting (COSM). Chicago, IL. May 20-21, 2016. 
2016 Taylor Z, Anderson S, Bush M. Addressing Pediatric Hearing Loss Educational 
and Practice Gaps in Primary Care Providers. World Congress on Continuing 
Professional Development. San Diego, CA. March 17-19, 2016. 
2016 Noblitt B, Bush M. Barriers and Outcomes of Cochlear Implantation 
Rehabilitation in Rural Appalachia. 15th Annual Early Hearing Detection and 
Intervention Meeting. San Diego, CA. March 13-15, 2016. 
2016 Hixon B, Chan S, Shinn J, Bush M. John E. Bordley, MD Resident Research 
Award (Southern Section). Assessment of Rural Adult Hearing Health 
Disparities--Access to Care in Cochlear Implantation. Triological Society 
Combined Section Meeting. Miami, FL. January 22-24, 2016. 
2015 Bush M, Christian J, Bianchi K, Lester C, Schoenberg N. Targeting Regional 
Pediatric Congenital Hearing Loss Using a Spatial Scan Statistic. National EHDI 
Meeting. Louisville, KY. March 9, 2015. 
2014 Alexander D, Noblitt B, Lester C, Shinn J, Bush M. Rural Primary Care Provider 
Knowledge and Practice Patterns of Congenital Hearing Loss.  Triological 
Society Annual Meeting - COSM. May 15-17, 2014. 
2014 Noblitt B, Alexander D, Lester C, Shinn J, Bush M. Rural Primary Care Provider 
Knowledge and Practice Patterns of Congenital Hearing Loss. 9th Annual CCTS 
Spring Conference University of Kentucky Center for Clinical and Translational 
Science, Lexington Convention Center, Lexington, Kentucky. March 27, 2014. 
2014 Bush M, Hardin B, Rayle C, Lester C, Studts C, Shinn J. Rural Barriers to Early 
Diagnosis and Treatment of Infant Hearing Loss in Appalachia. 9th Annual CCTS 
Spring Conference University of Kentucky Center for Clinical and Translational 
Science, Lexington Convention Center, Lexington, Kentucky. March 27, 2014. 
2013 Bush M, Bianchi K, Lester C, Shinn J, Gal TJ, Fardo D, Schoenberg N. 
Diagnostic Disparities of Pediatric Congenital Hearing Loss in Appalachia. 
Translational Science 2013, Washington, DC. April 18, 2013. 
2013 Bush M, Bianchi K, Osetinsky M, Shinn J. Bridging the Gap: Assessment of 
Hearing Healthcare Barriers in Appalachia. Early Detection Hearing and 
Intervention Annual Meeting, Glendale, AZ. April 15, 2013. 
2013 Roberts D, Bush M, Jones R. Adult Progressive Sensorineural Hearing Loss: Is 
pre-operative imaging necessary prior to cochlear implantation. American 
Neurotology Society Annual Meeting – COSM. Orlando, FL. April 12, 2013 
2013 Bush M, Bianchi K, Osetinsky M, Shinn J. Rural Pediatric Hearing Healthcare 
Disparity: Factors in Delayed Congenital Hearing Loss Diagnosis and 
Intervention. Triological Society Annual Meeting – COSM. Orlando, FL. April 12, 
2013. 
2013 Bush M, Burton M, Loan A, Shinn J. Timing Discrepancies of Early Intervention 
Hearing Services in Urban and Rural Cochlear Implant Recipients. American 
Otological Society Annual Meeting – COSM. Orlando, FL. April 12, 2013. 
2013 Osetinsky M, Shinn J, Fardo, Gal TJ, Schoenberg N, Bush M. Congenital 
Sensorineural Hearing Loss in Appalachia. AOA Groves Memorial MD/PhD 
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Program Student Research Symposium, University of Kentucky, Lexington, 
Kentucky. February 20, 2013. 
2012 Burns S, Akhmametyeva E, Oblinger J, Bush M, Huang J, Qian A, Senner V, 
Chen CS, Jacob A, Welling DB, Chang LS. AR-42, a Novel Histone Deacetylase 
Inhibitor, Differentially Affects Cell-Cycle Progression of Meningeal and 
Meningioma Cells and Potently Inhibits Tumor Growth in a Quantifiable NF2-
deficient Benign Meningioma Model. The 2012 NF Conference, New Orleans, 
LA. 
2012 Chang E, Bingcang C, Fornwalt B, Bush M, Gal T, Jones R, Shinn J. The Utility 
of Monothermal Caloric Testing in Screening for Vestibular Dysfunction. 
American Auditory Society Annual Meeting. March 2012. Scottsdale, AZ. 
2012 Burns S, Akhmametyeva E, Oblinger Huang J, Bush M, Senner V, Chen CS, 
Jacob A, Welling DB, Chang LS. AR-42, a Novel Histone Deacetylase Inhibitor, 
Causes G2 Arrest in Meningioma Cells while Arresting Normal Meningeal Cells 
at G1 and Potently Inhibits Tumor Growth in a Quantifiable NF2-deficient Benign 
Meningioma Model. The 14th Ohio State University Comprehensive Cancer 
Center Annual Scientific Meeting, Columbus, OH. 
2012 Burns S, Akhmametyeva E, Oblinger J, Huang J, Bush M, Senner V, Chen CS, 
Jacob A, Welling DB, Chang LS. AR-42, a Novel Histone Deacetylase Inhibitor, 
Causes G2 Arrest in Meningioma Cells while Arresting Normal Meningeal Cells 
at G1 and Potently Inhibits Tumor Growth in a Quantifiable NF2-deficient Benign 
Meningioma Model. The Research Institute at Nationwide Children’s Hospital 
2012 Research Week, Columbus, OH. The 2012 3rd Semi-Annual ONOC 
Meeting, Columbus, OH. 
2012 Burns, S.S., E.A. Akhmametyeva, J.L. Oblinger, M.L. Bush, J. Huang, A. 
Qian,  V. Senner, C.-S. Chen, A. Jacob, D.B. Welling, L.-S. Chang. 2012. AR-42, 
a Novel Histone Deacetylase Inhibitor, Differentially Affects Cell-Cycle 
Progression of Meningeal and Meningioma Cells and Potently Inhibits Tumor 
Growth in a Quantifiable NF2-deficient Benign Meningioma Model. The Research 
Institute at Nationwide Children’s Hospital 2012 Research Week, Columbus, OH 
2011 Walz P, Bush M, Robinett Z, Kirsch C, Welling DB. 3D Volumetric Conformal 
Analysis of Vestibular Schwannomas: Comparison of volumetric and linear 
measurements for estimation of sporadic vestibular schwannoma growth. 
American Academy of Otolaryngology – Head and Neck Surgery Annual 
Meeting, San Francisco, CA. September 11-14, 2011. 
2011 Bush M, Bratasz A, Brendel V, Manning A, Oblinger J, Chang LS, Welling DB, 
Jacob A, Powell K. The Use of Magnetic Resonance Spectroscopy (MRS) in 
Monitoring Vestibular Schwannoma Growth and Treatment Effect. Childrens 
Tumor Foundation NF Conference. Jackson Hole, WY. June 11-14, 2011. 
2011 Bush M, Oblinger J, Brendel V, Santarelli G, Huang J, Akhmametyeva E, Burns 
S, Wheeler, Davis J, Yates C, Chaudhury A, Kulp S, Chen C, Chang L, Welling 
D, Jacob A. AR42, A Novel Histone Deacetylase Inhibitor, as a Potential Therapy 
for Vestibular Schwannomas and Meningiomas. Childrens Tumor Foundation NF 
Conference. Jackson Hole, WY. June 11-14, 2011. 
2011 Bush M, Oblinger J, Brendel V, Santarelli G, Huang J, Akhmametyeva E, Burns 
S, Wheeler, Davis J, Yates C, Chaudhury A, Kulp S, Chen C, Chang L, Welling 
D, Jacob A. AR42, A Novel Histone Deacetylase Inhibitor, as a Potential Therapy 
for Vestibular Schwannomas and Meningiomas. The Ohio State University 
Annual Research Day, Columbus, OH. April 7, 2011. 
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2011 Bush M, Oblinger J, Davletova S, Burns S, Chang LS, Welling DB, Jacob A. 
Treatment of Vestibular Schwannoma Cells with ErbB Inhibitors. The Ohio State 
University Annual Research Day, Columbus, OH. April 7, 2011.  
2011 Bush, M, Oblinger J, Brendel V, Santarelli G, Huang J, Akhmametyeva E, Burns 
S, Wheeler, Davis J, Yates C, Chaudhury A, Kulp S, Chen C, Chang L, Welling 
D, Jacob A. AR42, A Novel Histone Deacetylase Inhibitor, as a Potential Therapy 
for Vestibular Schwannomas and Meningiomas. Nationwide Children’s Hospital 
Research Institute Research Week Spring 2011. 
2011 Burns S, Akhmametyeva E, Oblinger J, Bush M, Huang J, Senner V, Giovannini 
M, Chen CS, Jacob A, Welling DB, Chang LS. AR-42 and AR-12 Potently Inhibit 
the Growth of NF2-deficient Human Meningiomas. Nationwide Children’s 
Hospital Research Institute Research Week. April 4-8, 2011. 
2011 Burns S, Akhmametyeva E, Oblinger J, Bush M, Huang J, Senner V, Giovannini 
M, Chen CS, Jacob A, Welling DB, Chang LS. AR-42 and AR-12 Potently Inhibit 
the Growth of NF2-deficient Human Meningiomas. The Ohio State University 
Comprehensive Cancer Center Annual Conference. Columbus, Ohio. February 
18, 2011. 
2010 Hull B, Bush M, Yates C, Miles-Markley B, Chang LS, Welling DB. Assessment 
of Color Vision and Developmental Anomalies in Neurofibromatosis type 2 
Patients. The Ohio State University Annual Research Day, Columbus, OH. April 
8, 2010. 
2010 Davis J, Burns S, Bush M, Welling DB, Chang LS. Establishment of Benign and 
Malignant NF2-Deficient Meningioma Mouse Models. The Ohio State University 
Annual Research Day, Columbus, OH. April 8, 2010. 
2010 Oblinger J, Lee T, Packer M, Huang J, Bush M, Kulp S, Chen CS, Giovannini M, 
Welling DB, Jacob A, Chang LS. HDAC42 and OSU-03012, Novel Small-
Molecule Inhibitors for the Treatment of Vestibular Schwannomas. The Ohio 
State University Comprehensive Cancer Center Annual Conference. Columbus, 
Ohio. February 19, 2010. 
2010 Burns S, Bush M, Davis J, Welling DB, Chang LS. Intracranial Xenograft Models 
for Benign and Malignant NF2-Deficient Meningiomas. The Ohio State University 
Comprehensive Cancer Center Annual Conference. Columbus, Ohio. February 
19, 2010. 
2010 Oblinger J, Lee T, Packer M, Huang J, Bush M, Kulp S, Chen CS, Giovannini M, 
Welling DB, Jacob A, Chang LS. HDAC42 and OSU-03012, Novel Small-
Molecule Inhibitors for the Treatment of Vestibular Schwannomas. Nationwide 
Children’s Hospital Research Institute Research Week. Columbus, Ohio. April 7, 
2010. 
2010 Burns S, Bush M, Davis J, Welling DB, Chang LS. Intracranial Xenograft Models 
for Benign and Malignant NF2-Deficient Meningiomas. Nationwide Children’s 
Hospital Research Institute Research Week. Columbus, Ohio. April 5, 2010.  
2009 Bush M, Oblinger J, Burns S, Kulp S, Chen CS, Senner V, Jacob A, Welling DB, 
Chang LS. Preclinical Evaluation of HDAC Inhibitors and an EGFR Inhibitor on 
Vestibular Schwannoma and Meningioma. Childrens Tumor Foundation NF 
Conference. Portland, OR. June 13-16, 2009.  
2009 Bush M, Burns S, Kulp S, Chen CS, Jacob A, Welling DB, Chang LS. Mutation 
Analysis and In Vitro HDAC Inhibitor Treatment of Benign Human Meningioma 
Cells. The Ohio State University Medical Center Research Day, Columbus, OH. 
April 3, 2009. 
2007 Bush M, Jones R, Shinn J.  Test-Retest Reliability of VEMPS. American Auditory 
Society Meeting, Scottsdale, AZ.  March 4-7, 2007 
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2006 Bush M, Jones R, Musiek F & Shinn J. Auditory Brainstem Response and 
Behavioral Testing in Acoustic Neuroma Detection. American Auditory Society 
Meeting, Scottsdale, AZ.  March 5-7, 2006 
INVITED LECTURES 
 
2016 Bush M, Barry P, Thomlinson B. “’But He Wears Hearing Aids!’ – A Primer on 
Meeting the Holistic Needs of Children who are Hard of Hearing.” Systems of 
Care Academy. Lexington, KY. June 8, 2016. (Panel Discussion) 
2016 Studts T, Bush M. Interdisciplinary Research with Children: Examples from 
Biomedical and Behavioral Studies. University of Kentucky CCTS Clinical 
Research Update. Lexington, KY. May 10, 2016.  
2016 Bush M. Bridging the Gaps: Assessing and Addressing Hearing Health 
Disparities. Johns Hopkins University Center for Hearing and Balance Seminar 
Series. Baltimore, MD. April 7, 2016.  
2015 Bush M. Hearing Loss and Cochlear Implantation. Kentucky Academy of 
Physicians Assistants. Lexington, KY. November 5, 2015. 
2015 Bush M. Hearing Preservation in Cochlear Implantation. Hearing Loss 
Association of America, Kentucky Chapter Annual Meeting, Louisville, KY. 
September 12, 2015. 
2015 Bush M. Diseases of Balance and Equilibrium. Hearing Loss Association of 
America, Kentucky Chapter Annual Meeting, Louisville, KY. September 12, 2015. 
2015 Bush M. Family Perceptions and Experiences with the Early Hearing Detection 
and Intervention System in Rural Communities. National Center for Hearing 
Assessment and Management Webinar. August 11, 2015. 
http://www.infanthearing.org/resources_home/events/family-perceptions.html 
2015 Bush M. Bridging the Gaps: Assessing and Addressing Pediatric Rural Hearing 
Healthcare Disparities. Kentucky Academy of Audiology Annual Meeting, 
Lexington, KY. July 25, 2015. 
2015 Bush M. Not a Second to Lose! The Race for Auditory Development. Lexington 
Hearing and Speech Center Little Peeps Symposium, Lexington, KY. April 18, 
2015. 
2015 Bush M. Resident Quiz Bowl. Kentucky Society of Otolaryngology Annual 
Meeting. Lexington, KY. April 18, 2015. 
2015 Bush M. Hearing Preservation in Cochlear Implantation. Kentucky Speech and 
Hearing Association Annual Meeting, Lexington, KY. February 26, 2015. 
2015 Bush M. Bridging the Gaps: Assessment of Rural Pediatric Hearing Health 
Disparities. American Academy of Audiology eAudiology session, February 11, 
2015. 
2014 Bush M. An Update On Infant Hearing Loss And Diagnostic Testing. Family 
Medicine Review, Lexington, KY. May 12, 2014. 
2014 Bush M. Why Can't I Hear? An Overview of Hearing Loss Causes. Hearing Loss 
Association of Kentucky, Lexington Chapter, May 8, 2014. 
2014 Bush M. Bridging the Gaps: Assessing and Addressing Rural Pediatric Hearing 
Health Disparities. Indiana University DeVault Research Symposium Keynote 
Speaker. March 12, 2014. 
2013 Bush M. An Update On Infant Hearing Loss And Diagnostic Testing. Family 
Medicine Review, Lexington, KY. November 4, 2013. 
2013 Bush M. An Expanding Gap: Addressing Rural Hearing Healthcare Disparities 
and Delays. University of Kentucky Department of Otolaryngology 25th 
Anniversary Alumni Symposium. October 19, 2013. 
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2013 Bush M. Hearing Preservation in Cochlear Implantation. Hearing Loss 
Association of America, Kentucky Chapter Annual Meeting, Louisville, KY. July 
19, 2013. 
2013 Bush M. Pediatric Congenital Hearing Loss in Appalachia: Assessing and 
Addressing Diagnostic Delays. Hearing Loss Association of America, Kentucky 
Chapter Annual Meeting, Louisville, KY. July 19, 2013. 
2013 Bush M. A Pediatrician’s Guide to Healthy Ears. Contemporary Pediatrics 
Conference. Marriott Griffin Gate Resort, Lexington, KY. May 18, 2013. 
2013 Bush M. Hearing Preservation in Cochlear Implantation. Featured Session at the 
American Academy of Audiology AudiologyNOW! Annual Meeting, Anaheim, CA. 
April 6, 2013. 
2013 Bush M. Hearing Preservation in Cochlear Implantation. American Academy of 
Audiology eAudiology Session. April 6, 2013.  
2013 Bush M. Diagnostic and Therapeutic Inequities in Appalachian Pediatric 
Congenital Hearing Loss. Kentucky Speech and Hearing Association Annual 
Meeting, Lexington, KY. February 28, 2013. 
2013 Bush M. Neuroradiology and Related Neuroanatomy for the Audiologist. 
American Academy of Audiology eAudiology session, February 12, 2013. 
2012 Bush M. Breaking the Silence: An Overview of Cochlear Implantation. Hearing 
Loss Association of America, Kentucky (Bardstown) Chapter, October 22, 2012. 
2012 Bush M. Evaluation of Dizziness in the Primary Care Setting. Kentucky 
Association of Physician Assistants Annual Meeting. Lexington, KY October 21, 
2012. 
2012 Bush M. Horizon of Hope: Addressing Audiologic Barriers in East Africa. Heuser 
Hearing Institute Grand Rounds, Louisville, KY. June 27, 2012. 
2012 Bush M. Breaking the Silence: An Overview of Cochlear Implantation. Hearing 
Loss Association of Kentuckiana, Louisville Chapter, May 8, 2012. 
2012 Bush M. ENT Through the Lifespan: Caring for the Ear from Cradle to Grave. 
The Kentucky Coalition of Nurse Practitioners and Nurse Widwives 24th Annual 
Conference. Louisville, KY. April 18, 2012. 
2012 Bush M. Breaking the Silence: An Overview of Cochlear Implantation. Hearing 
Loss Association of America, Kentucky (Lexington) Chapter, March 1, 2012. 
2012 Bush M. Neuroradiology and Related Neuroanatomy for the Audiologist. 
University of Louisville Division of Audiology Grand Rounds, February 20, 2012. 
2011 Bush M. Pediatric Neuroradiology and Clinical Implications for the Pediatric 
Hearing Specialist. Ohio School Speech Pathology Educational Audiology 
Coalition Fall Conference, Columbus, OH. October 23, 2011. 
2011 Bush M. Neuroradiology and Related 3D Neuroanatomy for the Audiologist. 
Alabama Academy of Audiology Annual Meeting, Sandestin, FL. October 1, 
2011. 
2011 Bush M. Pediatric Neuroradiology and Neuroanatomy for the Hearing Specialist. 
Heuser Hearing Institute Grand Rounds, Louisville, KY. September 14, 2011. 
2011 Bush M. AR42, A Novel Histone Deacetylase Inhibitor, as a Potential Therapy 
for Vestibular Schwannomas and Meningiomas. The Ohio State University 
Annual Saunders Symposium, Columbus, OH. June 24, 2011. 
2011 Bush M. Vestibular Schwannoma: Update on Current Therapies and Potential 
Future Options. Kentucky Society of Otolaryngology Annual Meeting, Lexington, 
KY, May 21, 2011. 
2011 Bush M, Musiek F. Neuroradiology and Related 3D Neuroanatomy for the 
Audiologist. Featured Session at the American Academy of Audiology Annual 
Meeting, Chicago, IL. April 9, 2011.  
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2011 Bush M. Neuroradiology and Related Neuroanatomy for the Audiologist. Ohio 
Academy of Audiology Annual Meeting, Columbus, OH. February 19, 2011.  
2010 Bush M, Musiek F. Neuroradiology and Related 3D Neuroanatomy for the 
Audiologist. Featured Session at the American Academy of Audiology Annual 
Meeting, San Diego, CA. April 16, 2010.  
2009 Bush M, Musiek F. Neuroradiology and Related 3D Neuroanatomy for the 
Audiologist. Learning Lab at the American Academy of Audiology Annual 
Meeting, Dallas, TX. April 1, 2009.  
UNIVERSITY CURRICULUM/LECTURES 
 
2016 Bush M. Med 815 Introduction to Clinical Medicine. Advancing Your Career and 
Expanding Your Practice through Health Disparities Research. February 15, 
2016. 
2015 Bush M. Evaluation of Dizziness in the Primary Care Setting. University of 
Kentucky Department of Internal Medicine Resident Lecture Series. October 20, 
2015. 
2015 Bush M, Course Director. University of Kentucky Department of Otolaryngology 
– Head and Neck Surgery Grand Rounds Series. Ongoing lecture series given 
every 4th Wednesday of the Month. 
2015 Bush M. Med 815 Introduction to Clinical Medicine. Advancing Your Career and 
Expanding Your Practice through Health Disparities Research. July 15, 2015. 
2015 Bush M. Online Center for Hearing Health. CME modules for provider 
education. http://www.cecentral.com/node/1169 
2015 Bush M. Med 815 Introduction to Clinical Medicine. Advancing Your Career and 
Expanding Your Practice through Health Disparities Research. April 6, 2015. 
2015 Bush M, Co-Course Director. Resident Core Curriculum: Otology, Neurotology 
and Cranial Base Surgery. University of Kentucky, Lexington, KY. March, 2015. 
2015 Bush M. Physiology of Equilibrium and Hearing. University of Kentucky 
Department of Neurology Resident Lecture Series. February 2, 2015. 
2014 Bush M. Work-Life Balance: Is that even possible? Department of 
Otolaryngology Professionalism Lecture Series. University of Kentucky, 
Lexington, KY. November 5, 2014. 
2014 Bush M, Course Director. Resident Core Curriculum: Otolaryngologic 
Manifestations of Systemic Disease. University of Kentucky, Lexington, KY  
2014 Bush M and Valentino J. Congenital Hearing Loss. 1st year medical student 
Neuroanatomy/Neurophysiology Course. University of Kentucky, Lexington, KY. 
April 14-15, 2014. 
2014 Bush M. Research Design 102: Statistics for the Mathematically Challenged. 
Department of Otolaryngology Lecture Series. University of Kentucky, Lexington, 
KY. March 5, 2014. 
2014 Bush M. Research Design 101: A Dummies Guide to Clinical Research. 
Department of Otolaryngology Lecture Series. University of Kentucky, Lexington, 
KY. February 5, 2014.  
2013-14 Bush M, Clinical Otology: The Diagnosis and Management of Ear 
Disease. 3rd year medical student lecture. University of Kentucky, Lexington, KY.  
2013 Bush M and Valentino J. Evaluation of the Vestibular Patient. 1st year medical 
student Neuroanatomy/Neurophysiology Course. University of Kentucky, 
Lexington, KY. April 8, 2013.  
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2013 Bush M. Resident Core Curriculum: Neurotology and Cranial Base Surgery: The 
Facial Nerve: The Mother of All Cranial Nerves. University of Kentucky, 
Lexington, KY. March 27, 2013.  
2013 Bush M. Resident Core Curriculum: Neurotology and Cranial Base Surgery: 
Lesions of the Lateral Skull Base. University of Kentucky, Lexington, KY. March 
20, 2013.  
2013 Bush M. Resident Core Curriculum: Neurotology and Cranial Base Surgery: 
Cochlear Implantation. University of Kentucky, Lexington, KY. March 13, 2013.  
2013 Bush M. Resident Core Curriculum: Neurotology and Cranial Base Surgery: 
Approaches to the Skull Base. University of Kentucky, Lexington, KY. March 6, 
2013. 
2013 Bush M, Course Director. Resident Core Curriculum: Neurotology and Cranial 
Base Surgery. University of Kentucky, Lexington, KY. March, 2013. 
2013 Bush M. Resident Core Curriculum: Otology: Vestibular physiology and clinical 
evaluation and management of dizzy patients. University of Kentucky, Lexington, 
KY January 9, 2013. 
2012-13  Bush M, Clinical Otology: The Diagnosis and Management of Ear Disease. 3rd 
year medical student lecture. University of Kentucky, Lexington, KY.  
2012 Bush M. Management of Hearing Loss and Facial Nerve Injury in the Trauma 
Patient. Inter-Disciplinary Trauma Conference, November 27, 2012. 
2012 Bush M, Course Director. Resident Core Curriculum: Oral Board Preparation. 
University of Kentucky, Lexington, KY 
2012 Bush M. Neuroradiology and Clinical Implications for the Audiologist. University 
of Louisville Division of Audiology Grand Rounds, Louisville, KY. February 20, 
2012.  
2011 Bush M. Neuroradiology of the Temporal Bone. University of Kentucky 
Department of Otolaryngology. Lexington, KY. February 17, 2012.  
2011-12 Bush M, Clinical Otology: The Diagnosis and Management of Ear Disease. 3rd 
year medical student lecture. University of Kentucky, Lexington, KY.  
2011 Bush M, Course Director. Resident Core Curriculum: Otolaryngologic 
Manifestations of Systemic Disease. University of Kentucky, Lexington, KY 
2011 Bush M. Otology/Neurology Resident Core Curriculum: Facial Nerve: Anatomy 
and Pathology. Resident lecture. The Ohio State University, Columbus, OH. 
2011 Bush M. Clinical Otology: The Diagnosis and Management of Ear Disease. 3rd 
year medical student lecture. The Ohio State University, Columbus, OH. 
2010 Bush M. Otology/Neurology Resident Core Curriculum: Otosclerosis. Resident 
lecture. The Ohio State University, Columbus, OH. 
2010 Bush M. Otology/Neurology Resident Core Curriculum: Surgical Approaches to 
the Skull Base. Resident lecture. The Ohio State University, Columbus, OH. 
2010 Bush M. Clinical Otology: The Diagnosis and Management of Ear Disease. 3rd 
year medical student lecture. The Ohio State University, Columbus, OH. 
2009 Bush M. Clinical Otology: The Diagnosis and Management of Ear Disease. 3rd 
year medical student lecture. The Ohio State University, Columbus, OH. 
2009 Bush M. Otology/Neurology Resident Core Curriculum: Temporal Bone Trauma. 
Resident lecture. The Ohio State University, Columbus, OH. 
2009 Bush M. Basics of Temporal Bone Anatomy and Dissection. Annual Resident 
Temporal Bone Course. The Ohio State University, Columbus, OH. 
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REGIONAL/NATIONAL COURSES 
 
2013 Stryker Resident Temporal Bone Surgical Dissection Course. University of 
Cincinnati, March 9, 2013. Co-Course Directors: Ravi Samy and Matthew Bush.  
 
RESEARCH MENTORSHIP 
 
Medical Students: 
 Anita Shanker 2016-present 
• Helping Infants Get HEaring Resources: The HIGHER Patient 
Navigator Trial  
 Whitney Powell 2016-present 
• Understanding Adult Perspectives Regarding Hearing 
Healthcare  
 Tianshi (“Mike”) Liu 2016-present 
• Systematic review of the Effects of Cochlear Implants and 
adjunctive rehabilitation therapy on language perception and 
performance among Infants with Congenital CMV infection 
Diana Bigler 2016-present 
• Assessment of disruptive behavioral problems in children with 
hearing loss 
• Systematic Review of Disruptive Behavioral Problems Among 
Hearing Impaired Children  
 Kayla Williams 2016-present 
• Understanding Adult Perspectives Regarding Hearing 
Healthcare  
 Julie Johnson 2015-present 
• Current Trends in Evaluation and Management of Acoustic 
Neuromas 
 Kristen Burke 2015-present 
• Systematic Review of Disruptive Behavioral Problems Among 
Hearing Impaired Children   
• Validation of Remote Cochlear Implantation Candidacy 
Evaluations  
 Taylor Shackleford 2015-present 
• Systematic review of Patient Navigation for underserved and 
minority populations  
• Promoting Early Diagnosis of Congenital Hearing Loss with 
Patient Navigation 
• Primary mentor on Physician Scientist Mentored 
Research Fellowship 
 Vania Rashidi 2015-present  
• Assessment of disruptive behavioral problems in children with 
hearing loss  
• Primary mentor on Physician Scientist Mentored 
Research Fellowship 
 Stevie Maxwell 2015-present  
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• Assessment of long term outcomes for glomus jugulare 
patients tumors treated with gamma knife radiation   
 Stephen Chan 2014-2015 
• Hearing health and healthcare disparities in adult patients 
• Primary mentor on Physician Scientist Mentored 
Research Fellowship 
Bryce Noblitt 2013-2015 
• Analysis of cochlear implant rehabilitation barriers for rural 
pediatric cochlear implant recipients 
• Physician attitudes regarding pediatric hearing loss in rural 
Kentucky 
• Promoting Early Diagnosis of Congenital Hearing Loss with 
Patient Navigation 
• Primary mentor on Physician Scientist Mentored 
Research Fellowship 
Julia Elpers 2013-2014 
• Parental attitudes and experiences regarding pediatric hearing 
loss in rural Kentucky 
• Primary mentor on Physician Scientist Mentored 
Research Fellowship 
David Alexander (MS3-4) 2012 – 2013  
• Physician attitudes regarding pediatric hearing loss in rural 
Kentucky 
Mariel Osetinsky (MS2-4) 2011 – 2013  
• Investigation of delay of hearing healthcare for children with 
cochlear implants in Appalachia 
• Primary mentor on Physician Scientist Mentored 
Research Fellowship 
Kristin Bianchi (MS2-4) 2011 – 2013 
• Investigation of diagnostic challenges for children with severe 
hearing loss in rural Kentucky 
• Geospatial Scan Statistical Analysis of Patterns of Pediatric 
Hearing Loss in Kentucky 
Ashley Loan (MS2-4) 2012-2013 
• Investigation of hearing healthcare and rehabilitative services 
for children in Central Kentucky 
 William Dougherty (MS3-4) 2012-2013 
• Assessment of vestibular rehabilitation practice patterns and 
availability of care  
• A case-series review of pediatric autoimmune inner ear 
disease 
Ashleigh Long (MS2-4) 2011-2013 
• The clinical utility of magnetic spectroscopy in 
cerebellopontine angle tumors 
• The range of subjective symptoms in patients with normal pure 
tone audiometry 
• The Effect Operating Room Noise on Auditory Processing 
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Undergraduate Students:  
Nicholas Laureano 2016  
• Systematic Review of Disruptive Behavioral Problems Among 
Hearing Impaired Children   
  
 Residents: 
 Christopher Bingcang (PGY4-5) 2011-2012 
• The utility of monothermal caloric testing in screening for 
vestibular dysfunction 
 Joshua Dixon (PGY3-5) 2011-2014 
• The effect of middle ear effusion on cochlear implant function 
 German Fikhmann (PGY2-5) 2012 – 2015 
• Preservation of low-frequency hearing in cochlear implantation 
 Justin Way (PGY4-5) 2012-2013 
• Investigation of the effect of operating room noise on auditory 
processing 
 Deann Roberts (PGY4-5) 2012-2013 
• The clinical utility and cost-effectiveness of pre-operative 
imaging studies in cochlear implantation 
 Brian Hixon (PGY3-4) 2014-Present 
• Assessment of rural adult hearing healthcare disparities 
• Systematic review of barriers to hearing healthcare 
 Caitlin Fiorillo (PGY2-3) 2014-Present 
• Assessing and addressing disruptive behavioral problems in 
children with hearing loss 
Kyle Fletcher (PGY2) 2015-Present 
• Validation of Remote Cochlear Implantation Candidacy 
Evaluations 
• Systematic review of the Effects of Cochlear Implants and 
adjunctive rehabilitation therapy on language perception and 
performance among Infants with Congenital CMV infection 
Mark Ringstrom (PGY3-4) 2014-Present 
• MRI spectroscopy in the evaluation of cranial base tumors 
Andrew Ebelhar (PGY3-4) 2014-Present 
• Preoperative Assessment of Round Window Anatomy for 
Cochlear Implantation with Intention of Hearing Preservation 
via Round Window Insertion 
Mitch Dobberpuhl (PGY3) 2015-Present 
• Multidisciplinary Assessment of Clinical Symptoms and 
Treatment of Vestibular Migraines 
• Current Trends in Evaluation and Management of Acoustic 
Neuromas 
 Mike Kaufman 2016-present 
• Validation of Remote Cochlear Implantation Candidacy 
Evaluations 
• Systematic review of Patient Navigation for underserved and 
minority populations  
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Audiology Doctoral Students: 
Margaret Barnett (2015-2016) 
• Perspectives of Primary Care Medical Providers Regarding 
Adult Hearing Healthcare in the Rural Context 
JOURNAL PUBLICATIONS 
 
1. Chan S, Hixon B, Adkins M, Shinn J, Bush M. Rurality and Determinants of 
Hearing Healthcare in Adult Hearing Aid Recipients. Laryngoscope. 2017. (epub) 
2. Bush M, Thompson R, Irungu C, Ayugi J. The Role of Telemedicine in Auditory 
Rehabilitation: A Systematic Review. Otology & Neurotology. 2016. 37(10): 1466-
1474. 
3. Barnett M, Hixon B, Okwiri N, Irungu C, Ayugi J, Thompson R, Shinn J, Bush M. 
Factors Involved in Access and Utilization of Adult Hearing Healthcare: A 
Systematic Review. Laryngoscope. 2016. Aug 22. Epub. 
4. Hixon B, Chan S, Adkins M, Shinn J, Bush M. Timing and Impact of Hearing 
5.Healthcare in Adult Cochlear Implant Recipients: A Rural-Urban Comparison. 
Otology & Neurotology. 2016. 37(9):1320-4. 
5. Dobberpuhl MR, Maxwell S, Feddock J, St Clair W, Bush M. Treatment 
Outcomes for Single Modality Management of Glomus Jugulare Tumors with 
Stereotactic Radiosurgery. Otology & Neurotology. 2016. 37(9):1406-10. 
6. Shinn J, Long A, Rayle C, Bush M. Primary Auditory Symptoms in Patients with 
Normal Peripheral Hearing Sensitivity: Redefining Hearing Loss. Hearing, 
Balance and Communication. 2015. 14(1):44-49. 
7. Elpers J, Lester C, Shinn J, Bush M. Rural Family Perceptions and Experiences 
with Early Infant Hearing Detection and Intervention: A Qualitative Study. J 
Community Health. 2016. 41:226-233. PMID: 26316007 
8. Bush M, Dougherty W. Assessment of Vestibular Rehabilitation Therapy 
Training and Practice Patterns. J Community Health. 2015. 40(4):802-7. PMID: 
25700790 
9. Bush M, Alexander D, Noblitt B, Lester C, Shinn J. Pediatric Hearing Healthcare 
in Kentucky’s Appalachian Primary Care Setting. J Community Health. 2015. 
40(4):762-8. PMID: 25672888 
10. Dougherty W, Thatayatikom A, Bush M. Pediatric Autoimmune Inner Ear 
Disease: A Case Series. Hearing, Balance and Communication. 2015. 13(1): 32-
39. 
11. Bush M, Hardin B, Rayle C, Lester C, Studts C, Shinn J. Rural Barriers to Early 
Diagnosis and Treatment of Infant Hearing Loss in Appalachia. Otology & 
Neurotology 2015. 36(1): 93-98. PMID: 25325844 
12. Bush M, Christian J, Bianchi K, Lester C, Schoenberg N. Targeting Regional 
Pediatric Congenital Hearing Loss Using a Spatial Scan Statistic. Ear & Hearing. 
2015. 36(2): 212-6. PMID: 25225918 
13. Dixon J, Shinn J, Adkins M, Hardin B, Bush M. Middle Ear Disease and Cochlear 
Implant Function: A Case Study. Hearing, Balance and Communication. 2014 
Sept; 12(3): 155-158. 
14. Bush M, Osetinsky M, Shinn J, Gal T, Fardo D, Schoenberg N. Assessment of 
Appalachian Region Pediatric Hearing Healthcare Disparities and Delays. 
Laryngoscope. 2014 Jul; 124(7):1713-7. PMID: 24402802 PMCID: PMC4069222 
15. Bush M, Bianchi K, Lester C, Shinn J, Gal T, Fardo D, Schoenberg N. Delays in 
Diagnosis of Congenital Hearing Loss in Rural Children. J Pediatr 2014;164:393-
7. PMID: 24183213. PMCID: PMC3946850. 
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16. Roberts D, Bush M, Jones R. Adult Progressive Sensorineural Hearing Loss: Is 
pre-operative imaging necessary prior to cochlear implantation. Otology & 
Neurotology 2014 Feb;35(2):241-5. PMID: 24448283. 
17. Bush M, Burton M, Loan A, Shinn J. Timing Discrepancies of Early Intervention 
Hearing Services in Urban and Rural Cochlear Implant Recipients. Otology & 
Neurotology. 2013. 34(9): 1630-5. PMID: 24136305 PMCID: PMC3830638 
18. Way J, Long A, Weighing J, Ritchie R, Jones R, Bush M, Shinn J. The Effect of 
Noise on Auditory Processing in the Operating Room. Journal of the American 
College of Surgeons 2013. 216(5):933-8. PMID: 23518255. 
19. Bush M, Bingcang C, Chang E, Fornwalt B, Rayle C, Gal TJ, Jones R, Shinn J. 
Hot or Cold: Is Monothermal Caloric Testing Useful and Cost-Effective? Annals 
of Otology, Rhinology, & Laryngology. 2013. 122(6): 412-416. PMID: 23837395 
20. Burns S, Akhmametyeva E, Oblinger J, Bush M, Huang J, Senner V, Chen CS, 
Jacob A, Welling DB, Chang LS. AR-42, a Pan-Histone Deacetylase Inhibitor, 
Differentially Affects Cell-cycle Progression of Meningeal and Meningioma Cells 
and Potently Inhibits Tumor Growth in a Quantifiable NF2-deficient Benign 
Meningioma Model. Cancer Research. Jan 15, 2013. 73(2): 792-803. PMID: 
23151902 
21. Walz P, Bush M, Robinett Z, Kirsch C, Welling DB. 3D Volumetric Conformal 
Analysis of Vestibular Schwannomas: Comparison of volumetric and linear 
measurements for estimation of sporadic vestibular schwannoma growth. 
Otolaryngology – Head and Neck Surgery. 2012 Oct; 147(4): 737-43. PMID: 
22588731 
22. Bush M, Oblinger J, Davletova S, Burns S, Chang LS, Welling DB, Jacob A. 
Treatment of Vestibular Schwannoma Cells with ErbB Inhibitors. Otology & 
Neurotology. 2012 Feb; 33(2):244-57. PMID: 22222570  
23. Cipolla MJ, Iyer P, Dome C, Welling DB, Bush M. Modification and Comparison 
of Minimally-Invasive Cochleostomy Techniques:  A Pilot Study. Laryngoscope. 
2012 May; 122(5): 1142-7. PMID: 22447373. 
24. Jacob A, Oblinger J, Bush M, Brendel V, Santarelli G, Chaudhury AR, Kulp S, La 
Perle KMD, Chen CS, Chang LS, Welling DB. Preclinical Validation of AR42, a 
Novel Histone Deacetylase Inhibitor, as Treatment for Vestibular Schwannomas. 
Laryngoscope. 2012 Jan; 122(1):174-89. PMID: 22109824. 
25. Bush M, Oblinger J, Brendel V, Santarelli G, Huang J, Akhmametyeva E, Burns 
S, Wheeler, Davis J, Yates C, Chaudhury A, Kulp S, Chen C, Chang L, Welling 
D, Jacob A. AR42, A Novel Histone Deacetylase Inhibitor, as a Potential Therapy 
for Vestibular Schwannomas and Meningiomas. Neuro Oncology 2011 Sep. 
13(9): 983-99. PMID: 21778190. 
26. Bush M, Pritchett C, Packer M, Ray-Chaudhury, A, Jacob A.  
Hemangioblastoma of the Cerebellopontine Angle.  Archives of Otolaryngology – 
Head and Neck Surgery.  2010 Jul; 136(7): 734-8. PMID: 20644074. 
27. Bush M, Jones R, Shinn J.  The Clinical Reliability of Vestibular Evoked 
Myogenic Potentials. Ear, Nose, and Throat Journal 2010 Apr; 89(4): 170-6. 
PMID: 20397145. 
28. Shinn J, Bush M, Jones R.  Correlation of Central Auditory Processing Deficits 
and Vascular Loop Syndrome. Ear, Nose, and Throat Journal. 2009 
Oct;88(10):E34-7. PMID: 19826989. 
29. Bush M, Jones R, Givens C. The value of CT venography in the diagnosis of 
jugular bulb diverticulum: A series of 3 cases. Ear, Nose, and Throat Journal. 
2009 April; 88(4):E04. PMID: 19358118. 
30. Bush M, Jones R, Shinn J.  Auditory Brainstem Response Threshold Differences 
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in Patients with Vestibular Schwannoma:  A New Diagnostic Index. Ear, Nose, 
and Throat Journal. 2008 Aug; 87(8):458-62. PMID: 18712694. 
31. Bush M, Shinn J, Young AB, Jones R.  Long-term Hearing Results in Gamma 
Knife Radiosurgery for Acoustic Neuromas. Laryngoscope.  2008 Jun; 118(6): 
1019-22. PMID: 18364592. 
32. Bush M, Gupta S.  Lilliputian Hallucinations and Marijuana Dependence in a 
Bipolar Patient.  The Jefferson Journal of Psychiatry.  2002.  17(1): 68-72. 
BOOKS AND BOOK CHAPTERS 
 
Bush M, Welling DB. Cerebellopontine Angle Tumors, in Head and Neck Surgery – 
Otolaryngology, 5th Johnson JT and Rosen CA, eds. Philadelphia: Lippincott Williams 
& Wilkins. 2013. ISBN: 9781609136020. 
Bush M, Welling DB. Neurofibromatosis Type 2, in The Five Minute Neurology Consult, 
2nd ed. Lynn DJ, Newton HB, Rae-Grant AD, eds. Philadelphia: Lippincott Williams & 
Wilkins. 2012. ISBN: 9781451100129 
Bush M. Diseases of the external and middle ear, in Disorders of the Auditory System, 
Musiek F, Baran J, Shinn J, Jones R, eds. San Diego: Plural Pub. 2012. 
Bush M. Diseases of the cochlea, in Disorders of the Auditory System, Musiek F, Baran 
J, Shinn J, Jones R, eds. San Diego: Plural Pub. 2012. 
CURRENT RESEARCH FUNDING 
  
2/2016 – 2/2018 Advanced Bionics Sponsored Clinical Trial 
Title: Implantation of the HiRes90K™ Advantage Cochlear Implant 
with HiFocus™ Mid-Scala and Development of a Combined Electric 
and Acoustic Stimulation Technology in Adults with Partial Deafness 
($97,939) 
Role: PI                                                                                         
 
3/2015 – 3/2018 NIH/NIDCD Career Development Award (1 K23 DC014074-01) 
“Promoting Early Diagnosis of Congenital Hearing Loss through 
Patient Navigation” ($685,149) 
 Role: PI  
 
7/2011 – 7/2017 University of Kentucky College of Medicine Start-up Funds 
($225,000)  
 
COMPLETED RESEARCH FUNDING 
  
2/2015 – 8/2016 University of Kentucky CCTS Junior Investigator Pilot Award 
(UL1TR000117) 
 “Assessing and Addressing Disruptive Behavioral Problems in Children with Hearing 
Loss” ($25,000) 
 Role: Co-PI 
8/2014 – 7/2016  AAO-HNSF:  Triological Society Career Development Award 
 “Promoting Early Diagnosis of Congenital Hearing Loss through Patient Navigation” 
($40,000) 
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 Role: PI 
11/2012 – 11/2015 NIH/NIDCD (1U24-DC012079-01) Resources for Mentorship of 
Clinician Scientists in Hearing and Balance Disorders 
 Mentored research grant to support career development of early clinician scientists 
7/2012 – 2/2015 NIH KL2 Award (8 KL2 TR000116-02) 
 “Bridging the Gaps: Assessment of Pediatric Hearing Loss in Appalachia” 
10/2012 – 10/2014 NIH Health Disparities Loan Repayment Award        
“Pediatric Hearing Loss in Rural Appalachia: Assessment of Successful Identification 
and Timely Intervention.” 
7/2009 – 12/2010 American Hearing Research Foundation Wiley H. Harrison 
Grant AAO-HNS CORE grant, Principal Investigator 
 “In vitro and in vivo response to HDAC inhibitors by vestibular schwannomas” 
($25,000). 
INTERNATIONAL HUMANITARIAN EFFORTS  
 
 Development of the Sikiza Society, an international academic collaboration between 
the University of Kentucky and the University of 
Nairobi: http://www.entnet.org/content/humanitarian-efforts-map 
• Call of Duty: Personal, Professional Merits of Humanitarian 
Work. ENTtoday. June 5, 2016. 
http://www.enttoday.org/article/call-duty-personal-
professional-merits-humanitarian-
work/?elq_mid=10215&elq_cid=3437612 
CURRENT RESEARCH INTERESTS  
• Rural Hearing Health Disparities 
• Disruptive behavioral problems in Children with Hearing Loss 
• Hearing Preservation in Cochlear Implantation 
• MRI spectroscopy in cranial base tumors 
CURRENT CLINICAL INTERESTS  
• Adult and Pediatric Hearing Loss 
• Cochlear implantation 
• Tumors of the lateral cranial base and stereotactic radiosurgery 
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MEDIA RELEASES 
 
“Rural children face delays in diagnosis of congenital hearing loss.” Reuters Health 
News. November 21, 2013. http://www.thedoctorschannel.com/view/rural-children-
face-delays-in-diagnosis-of-congenital-hearing-loss/ 
 
“Prescribing Patterns for Otitis Media in Children.” Eastern Kentucky University Morning 
Edition, Radio Interview. February 26, 2013. 
 
“Too Much Background Noise in the Operating Room Can Impair Communication Among 
Surgical Team Members.” American College of Surgeons Press Release. May 10, 
2013. http://www.eurekalert.org/pub_releases/2013-05/acos-bni051013.php 
 
“Noise in the Operating Room.” BBC Radio Interview. May 13, 2013. 
 
“UK Otolaryngologist Works to Address Rural Disparities of Pediatric Hearing Loss” 
UKNow University of Kentucky News. April 11, 
2014. http://uknow.uky.edu/content/uk-otolaryngologist-works-address-rural-
disparities-pediatric-hearing-loss 
 
“Ear, nose, and throat doctor at UK aims to reduce state’s high rate of hearing loss 
among children.” Lane Report, April 15, 2014 
http://www.lanereport.com/30997/2014/04/ear-nose-and-throat-doctor-at-uk-aims-to-
reduce-states-high-rate-of-hearing-loss-among-
children/?utm_source=Faster%20Lane%20Newsletter&utm_medium=Email&utm_ca
mpaign=april-15-2014 
 
“Interdisciplinary Study of Behavioral Problems in Children with Hearing Loss Gains 
CCTS Funding” UKNow University of Kentucky News. February 12, 
2015. http://uknow.uky.edu/content/interdisciplinary-study-behavioral-problems-
children-hearing-loss-gains-ccts-funding 
 
“KL2 Program Fosters Collaborative Research on Hearing Loss, Behavioral Disorders in 
Appalachia” UKNow University of Kentucky News. September 29, 
2015. http://reveal.uky.edu/bush_studts 
 
“Music to their Ears: Musicians Join UK Patients and Faculty to Raise Awareness for 
Pediatric Cochlear Implant Program” UKnow University of Kentucky News. November 
12, 2015. http://uknow.uky.edu/content/music-their-ears-musicians-join-uk-patients-
and-faculty-raise-awareness-pediatric-cochlear-i 
UK physician’s patient navigator program ensures follow-up hearing tests for infants. UK 
OnCall Magazine. Issue 6, November 2015. 
 
UK’s Collaborative Research Environment. http://research.med.uky.edu/news/uk’s-
collaborative-research-environment 
 
Rural Access to Care and Telemedicine 
https://www.youtube.com/watch?v=fDQpJtnl96g&index=14&list=PLT_--N4wea5DIAN-
7ePL477QMS_AYQ6Wd 
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Call of Duty: Personal, Professional Merits of Humanitarian Work. ENTtoday. June 5, 
2016. http://www.enttoday.org/article/call-duty-personal-professional-merits-
humanitarian-work/?elq_mid=10215&elq_cid=3437612 
 
UK Surgeon-Researcher Works to Extend Cochlear Implant Program to Appalachia. 
UKNow University of Kentucky News. July 14, 2016. 
http://uknow.uky.edu/content/uk-surgeon-researcher-works-extend-cochlear-implant-
program-appalachia 
 
Giving the Gift of Hearing, Here and Around the 
World. http://ukhealthcare.net/blog/making-the-rounds-with-dr-matthew-bush/ 
 
Songs for Sound event benefits UK Cochlear Implant 
Program. http://ukhealthcare.net/blog/songs-for-sound-event-cochlear-implant/ 
 
 
 
